Gemma ID,External ID,Study Description,Number of Samples,Study Category,Condition Description,Control Description,Number of DE genes,Funding Source,DE Prior AUROC (Fig 2),CXCL8 DE,Sex (Fig 3),Immunity (Fig 3),Funding Prior AUROC (Fig 4),"DE Prior AUROC (222 subset, Fig 4)",Cluster Prior AUROC (Fig 4),NIGMS sepsis or trauma (Fig 4),Max GO term (Fig 4),Max GO AUROC (Fig 4)
RSCID.448367.34660,E-MEXP-2280,Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways,31,sex,female,male,1,NA,1,no,no,no,NA,NA,NA,no,GO:0042571,0.5
RSCID.457709.80233,GSE10063,Effects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia,60,treatment,vehicle,tobacco smoke,2,NA,0.939,no,no,no,NA,NA,0.75,no,GO:0019825,0.999
RSCID.449307.39104,GSE10245,Gene expression differences between adenocarcinoma and squamous cell carcinoma in human NSCLC,58,disease,Squamous cell carcinoma,Adenocarcinoma,317,NA,0.847,no,no,no,NA,NA,0.603,no,GO:0009888,0.566
RSCID.446720.33997,GSE10281,Letrozole (Femara) early response to treatment,36,treatment,2.5 mg/day; Post-treatment; letrozole,Pre-treatment; reference subject role,15,NCI NIH HHS,0.907,no,no,no,0.888,0.892,0.538,no,GO:1903047,0.732
RSCID.463657.117982,GSE10282,In-transit extremity melanoma I,43,genotype,mutant; BRAF [human] v-raf murine sarcoma viral oncogene homolog B,wild type genotype,104,NA,0.809,yes,no,no,NA,NA,NA,no,GO:0045595,0.538
RSCID.457721.80150,GSE10311,Systematic Assessment of Human Osteoblast Transcriptome in Resting and Induced Primary Cells,21,timepoint,24 hours,2 hours,25,NA,0.929,no,no,no,NA,NA,0.521,no,GO:0007186,0.628
RSCID.458573.80097,GSE10315,Multipotent mesenchymal stromal cells: identification of pathways common to TGF?3/BMP2-induced chondrogenesis,9,treatment,7 days; TGFB3; Growth Factor,reference subject role,320,NA,0.888,no,no,no,NA,NA,0.894,no,GO:0009888,0.536
RSCID.458589.80309,GSE10327,mRNA expression data of 62 human medulloblastoma tumors,62,sex,male,female,9,NA,0.982,no,yes,no,NA,NA,1,no,GO:0060765,0.583
RSCID.447940.21075,GSE10334,Transcriptomes in Healthy and Diseased Gingival Tissues,247,organism part,affected site; Periodontitis,unaffected site; reference subject role,9,NA,0.983,no,no,no,NA,NA,1,no,GO:0050864,0.665
RSCID.459299.40100,GSE10406,Mucus overproduction,18,clinical history,chronic rhinosinusitis,reference subject role,44,NA,0.871,no,no,no,NA,NA,0.548,no,GO:0006952,0.655
RSCID.454864.79913,GSE10718,Time course of NHBE cells exposed to whole cigarette smoke (full flavor),24,treatment,reference substance role,cigarette smoke,12,NA,0.575,yes,no,no,NA,NA,0.522,no,GO:0006352,0.606
RSCID.458597.80155,GSE10780,Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue,185,disease,invasive ductal carcinoma,Unremarkable breast ducts (Normal); reference subject role,116,NCI NIH HHS,0.945,no,no,no,0.928,0.922,0.986,no,GO:0009888,0.565
RSCID.458770.19098,GSE10799,Gene expression profile of lung tumors,13,disease,"lung adenocarcinoma; neoplastic, metastatic",reference subject role,588,NA,0.895,no,no,no,NA,NA,0.858,no,GO:0006928,0.541
RSCID.458985.19893,GSE10810,"Gene expression signatures in breast cancer distinguish phenotype charact., histological subtypes, and tumor invasivness",58,disease,Tumour,reference subject role,389,NA,0.893,no,no,no,NA,NA,0.964,no,GO:1901700,0.535
RSCID.456491.19402,GSE10831,HL cell line associated gene expression changes compared with CD10+ GC B cells,6,cell line,KMH2,GC,1508,NA,0.771,yes,no,no,NA,NA,0.788,no,GO:0006955,0.521
RSCID.459973.111163,GSE10843,mRNA Cancer Cell Line Profiles,5,cell line,Caco2,H1155,1679,NA,0.795,no,no,no,NA,NA,0.814,no,GO:0009888,0.526
RSCID.466763.123934,GSE10846,Prediction of survival in diffuse large B cell lymphoma treated with chemotherapy plus Rituximab,420,treatment,rituximab,reference substance role,279,NA,0.697,no,no,no,NA,NA,0.661,no,GO:0030054,0.542
RSCID.458621.81115,GSE10916,In vitro study of gene expression and response to chemotherapy across 50 human-melanoma derived cell lines,50,treatment,melphalan,temozolomide; melphalan,2,NA,0.793,no,no,no,NA,NA,0.467,no,GO:1903053,0.749
RSCID.458724.19520,GSE10961,Gene expression profiling of liver metastases from colorectal cancer,18,disease,Synchronous,Metasynchronous,930,NA,0.801,no,no,no,NA,NA,0.829,no,GO:0006082,0.564
RSCID.456506.19623,GSE10979,A study of temporal transcriptional changes induced by a low concentration BPDE in cultured human cells,18,treatment,BPDE; 0.05 uM,dimethyl sulfoxide; reference subject role,8,NA,0.84,no,no,no,NA,NA,0.665,no,GO:0017111,0.608
RSCID.445666.86331,GSE11057,Memory T Cell Subsets,9,cell type,mononuclear cell,memory T cell; Central,1073,NA,0.79,yes,no,no,NA,NA,0.705,no,GO:0006952,0.553
RSCID.445657.86358,GSE11058,Immune Cell Line Mixtures,6,cell line,IM-9,Jurkat cell culture,2166,NA,0.739,no,no,no,NA,NA,0.743,no,GO:0006955,0.532
RSCID.461560.75190,GSE11078,A six-gene signature predicting breast cancer lung metastasis,23,organism part,lung,reference subject role,32,NA,0.861,no,no,no,NA,NA,0.53,no,GO:0030141,0.607
RSCID.456661.19214,GSE11083,Childhood Onset Rheumatic Disease Gene Expression Profile,29,cell type,pediatric control PBMC,JIA PBMC,4,NA,0.911,no,no,yes,NA,NA,0.492,no,GO:0030659,0.741
RSCID.448968.65111,GSE11151,Gene expression data from different types of renal tumors and normal kidneys,67,disease,tumorous; kidney,reference subject role,376,NA,0.766,no,no,no,NA,NA,0.767,no,GO:0009888,0.529
RSCID.458634.81666,GSE11190,Interferon signaling and treatment outcome in chronic hepatitis C,78,organism part,liver,blood,2893,NA,0.778,yes,no,no,NA,NA,0.781,no,GO:0006082,0.54
RSCID.456645.19293,GSE11199,Identification of Tuberculosis Susceptibility Genes with Human Macrophage Gene Expression Profiles,24,treatment,Mycobacterium Infections,reference subject role; phosphate buffered saline solution,187,NA,0.884,yes,no,no,NA,NA,0.875,no,GO:0034097,0.592
RSCID.445189.81631,GSE11238,Vaccinia E3L mutant virus infected HeLa cell lines (langl-affy-human-215499),26,timepoint,6 hours,2 hours,1584,NA,0.604,yes,no,no,NA,NA,0.58,no,GO:0048468,0.514
RSCID.456427.19644,GSE11285,"GSK3 inhibition Induces Glioma Cell Death through c-MYC, NF-kB and Glucose Regulation",18,treatment,Enzastaurin; antineoplastic drug,dimethyl sulfoxide; reference subject role,4,NA,0.918,no,no,no,NA,NA,0.874,no,GO:0044241,0.75
RSCID.449155.75594,GSE11336,Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia,12,treatment,0.1% ethanol,100nM dexametasone,31,NA,0.832,no,no,no,NA,NA,NA,no,GO:0009968,0.572
RSCID.459122.75571,GSE11350,Generation of pluripotent stem cells from adult human testis,9,cell type,germ line stem cell,spermatogonium,2557,NA,0.67,yes,no,no,NA,NA,0.703,no,GO:0022402,0.521
RSCID.457793.81756,GSE11375,A Genomic Score Prognostic of Outcome in Trauma Patients,184,disease,"Severe blunt trauma; Trauma, Nervous System",reference subject role,257,NIGMS NIH HHS,0.876,no,no,yes,0.965,0.899,0.977,yes,GO:0006955,0.575
RSCID.457791.81595,GSE11428,Expression data from LNCaP and abl cells,21,cell line,LNCaP,abl,232,NA,0.837,no,no,no,NA,NA,0.704,no,GO:0048468,0.534
RSCID.443291.1173,GSE1145,changes in cardiac transcription profiles brought about by heart failure,26,disease,idiopathic dilated,normal,79,NA,0.707,no,no,no,NA,NA,0.572,no,GO:0008285,0.551
RSCID.457878.86352,GSE11462,Transcriptional response of MM6 cells to cyclin T1,23,treatment,10 ng/mL; PMA; phorbol esters,Mock treatment; reference substance role,137,NIAID NIH HHS,0.897,no,no,no,0.773,0.881,0.638,no,GO:0009888,0.548
RSCID.459021.19969,GSE11499,Expression data from Crohn's disease (CD) and Ulcerative colitis (UC) human peripheral blood samples,11,clinical history,Crohn's disease,Ulcerative colitis,1,NA,0.955,no,no,no,NA,NA,0.999,no,GO:0009887,0.988
RSCID.448370.34881,GSE11512.1,Gene expression changes during human postnatal brain development,57,organism part,Caudate nucleus,Prefrontal cortex,380,NA,0.762,no,no,no,NA,NA,0.721,no,GO:0097458,0.551
RSCID.459396.39597,GSE11524,The platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease,30,disease,Sickle Cell Anemia,reference subject role,24,Intramural NIH HHS,0.821,no,no,yes,0.581,0.789,NA,no,GO:0016491,0.597
RSCID.456559.18253,GSE11618,Stable XIAP knockdown in HCT116 colon cancer cells,10,genotype,knock-down; XIAP [human] X-linked inhibitor of apoptosis,wild type,5,NA,0.8,no,no,no,NA,NA,0.699,no,GO:0010955,0.699
RSCID.457788.81599,GSE11729,H1299 EGF and Iressa stimulation,40,cell line,L858R; mutant,WT; wild type genotype,37,NA,0.904,no,no,no,NA,NA,NA,no,GO:0030054,0.559
RSCID.457814.81761,GSE11755,Gene expression profiling in pediatric meningococcal sepsis reveals dynamic changes in NK-cell and cytotoxic molecules,41,disease,meningococcal septicemia,reference subject role,57,NA,0.936,no,no,yes,NA,NA,0.768,no,GO:0006955,0.597
RSCID.456726.19027,GSE11791,Estrogen- and Myc-regulated genes in MCF-7 breast cancer cells,12,treatment,ethanol,zinc,46,NA,0.872,no,no,no,NA,NA,0.778,no,GO:2001233,0.561
RSCID.466783.123981,GSE11877,Children's Oncology Group Study 9906 for High-Risk Pediatric ALL,207,genotype,Human chromosome 10; Human chromosome 4; trisomy,wild type genotype,7,NCI NIH HHS,0.63,no,no,no,0.557,0.607,0.718,no,GO:0045892,0.69
RSCID.456528.19434,GSE11882,Gene expression changes in the course of normal brain aging are sexually dimorphic,172,sex,male,female,8,NA,0.999,no,yes,no,NA,NA,1,no,GO:0051704,0.647
RSCID.450024.68324,GSE11906,Quality Control in Microarray Assessment of Gene Expression in Human Airway Epithelium,68,organism part,large airway epithelial cells,small airway epithelial cells,540,NHLBI NIH HHS,0.785,yes,no,no,0.637,0.773,0.515,no,GO:0009888,0.53
RSCID.457801.81549,GSE11917,Vitamin D sterol effects on coronary ASMC genes,27,timepoint,7 days,reference subject role,49,NA,0.945,no,no,no,NA,NA,0.571,no,GO:0031012,0.647
RSCID.459095.65102,GSE11952,Coordinate Control of Nrf2 Mediated Genes in the Human Small Airway Epithelium Highly Responsive to Smoking,55,clinical history,Smoking,Non smoking,7,NHLBI NIH HHS,0.979,no,no,no,0.996,0.989,1,no,GO:0016491,0.817
RSCID.445225.81676,GSE12056,Expression Profile of CREB knockdown in Myeloid Leukemia Cells,20,genotype,KO; CREB5 [human] cAMP responsive element binding protein 5,reference subject role,32,NHLBI NIH HHS,0.737,no,no,no,0.651,0.718,0.54,no,GO:0030155,0.591
RSCID.458659.81486,GSE12086,Search for recessive retinitis pigmentosa genes using RNA expression analysis in lymphoblasts,15,disease,Family; retinitis pigmentosa,Normal; reference subject role,1,NHLBI NIH HHS,0.997,no,no,no,0.99,0.988,1,no,GO:0000982,0.993
RSCID.458849.19045,GSE12108,Microarray analysis of human monocytes infected with Francisella tularensis,10,treatment,Uninfected,F. novicida infected,998,NCI NIH HHS,0.745,yes,no,no,0.707,0.745,0.632,no,GO:0002684,0.537
RSCID.456860.20174,GSE12113,"Antitumor Activity and Molecular Effects of the Novel Hsp 90 Inhibitor, IPI-504, in Pancreatic Cancer",15,treatment,Retaspimycin; antineoplastic drug,reference subject role,30,NA,0.708,no,no,no,NA,NA,0.562,no,GO:0045892,0.619
RSCID.447559.65004,GSE12121,Gingival Epithelial Cell Responses to a Complex Microbiome Comprising Commensal and Opportunistic Oral Microbial Species,8,treatment,Porphyromonas infection; Streptococcus gordonii,reference subject role,109,NA,0.643,no,no,no,NA,NA,0.551,no,GO:0000975,0.547
RSCID.458662.81473,GSE12172,Common activation of RAS_MAPK pathway in serous LMP tumours,90,disease,low malignant potential (LMP); ovarian cancer,ovarian serous tumor; malignant,207,NA,0.82,no,no,no,NA,NA,0.63,no,GO:0015630,0.57
RSCID.457824.81502,GSE12187,Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Genomic Profiling of Peripheral Blood,58,treatment,Calcineurin Inhibitor; cyclosporin A,advagraf; tacrolimus; FK506; immunosuppressive; protopic; prograf,379,NIAID NIH HHS,0.774,yes,no,no,0.744,0.771,0.829,no,GO:0006952,0.559
RSCID.457827.81491,GSE12195,Mutations of multiple genes deregulate the NF-kB pathway in diffuse large B cell lymphoma,78,cell type,Diffuse large B-cell lymphoma; DLBCL; Lymphoma,EBV-immortalized lymphoblastoid B cell; B cell; Lymphoblast,527,NCI NIH HHS,0.892,no,no,no,0.852,0.876,0.724,no,GO:0006955,0.543
RSCID.458710.19497,GSE12205,Effect of PTP inhibition on changes in gene expression after Cr(VI) exposure,8,treatment,Cr(VI) + Sodium Orthovanadate,reference subject role,5,NA,0.798,no,no,no,NA,NA,0.498,no,GO:0033043,0.975
RSCID.459383.64895,GSE12251,A Predictive Response Signature to Infliximab Treatment in Ulcerative Colitis,23,treatment,10 mg/kg,5 mg/kg,3,NA,0.975,no,no,no,NA,NA,NA,no,GO:0006955,0.814
RSCID.449083.75623,GSE12287,Bioligical pathways of Hsp90 inhibitors in adult T cell leukemia cell lines,14,cell line,MT-2,TaY-E10,2245,NA,0.716,yes,no,no,NA,NA,0.675,no,GO:0051240,0.521
RSCID.458668.19359,GSE12326,A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia,10,organism part,Peripheral Blood,Bone Marrow,2,NA,0.998,no,no,no,NA,NA,0.75,no,GO:0007193,0.748
RSCID.446654.20204,GSE12345,Global gene expression profiling of human pleural mesotheliomas,13,clinical history,healthy control,mixed type tumours,117,NA,0.854,no,no,no,NA,NA,NA,no,GO:0007049,0.607
RSCID.458928.65065,GSE12355,"Detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells",24,phenotype,Notch2-IC,reference subject role,25,NA,0.909,no,no,no,NA,NA,0.57,no,GO:0015630,0.628
RSCID.456756.20211,GSE12368,Analysis of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas,22,disease,Adrenal Cortical Adenoma,reference subject role,63,NA,0.88,no,no,no,NA,NA,0.622,no,GO:0048699,0.58
RSCID.457828.81469,GSE12390,A high efficiency system for the generation and study of human induced pluripotent stem cells,15,cell line,primary; induced; BJ; pluripotent stem cell,BJ; reference subject role,2132,NA,0.805,no,no,no,NA,NA,0.845,no,GO:0007049,0.525
RSCID.458971.20006,GSE12408,Defective Cohesin in CdLS Mediates Gene Expression with Characteristics of Transcription Factor and Insulator Activity,35,disease,Bruck-de Lange syndrome,reference subject role,6,NICHD NIH HHS,0.884,no,no,no,0.476,0.845,NA,no,GO:0002460,0.665
RSCID.459432.39817,GSE12446,Endometrium of hormone-treated postmenopausal women,18,treatment,tibolone,reference substance role,87,NA,0.771,no,no,no,NA,NA,0.515,no,GO:0005929,0.549
RSCID.458853.19042,GSE12452,mRNA expression profiling of nasopharyngeal carcinoma,41,disease,Carcinoma of Nasopharynx,reference subject role,188,NCI NIH HHS,0.851,no,no,no,0.823,0.829,0.677,no,GO:0006928,0.558
RSCID.459429.39838,GSE12453,Origin and pathogenesis of lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis,17,disease,Hodgkin lymphoma,centrocyte,759,NA,0.773,no,no,no,NA,NA,0.791,no,GO:0006955,0.544
RSCID.459568.71575,GSE12504,Hearts after off-pump coronary revascularization surgery and on-pump coronary artery bypass grafting,20,timepoint,post-operation,pre-operation,3,NA,0.991,no,no,no,NA,NA,0.82,no,GO:0071495,0.979
RSCID.457774.81145,GSE12548,EMT Time series in ARPE19,5,timepoint,60 hours,1 hours,329,NA,0.837,no,no,no,NA,NA,0.841,no,GO:0040011,0.542
RSCID.445214.38999,GSE12621,Expression data in the developing human retina at 19-20 weeks' gestation,8,organism part,Surround,Macula,19,NA,0.808,no,no,no,NA,NA,NA,no,GO:0016491,0.615
RSCID.459114.20235,GSE12644,Gene expression profile of normal and calcified stenotic human aortic valves,20,treatment,healthy control,aortic stenosis,19,NA,0.949,no,no,no,NA,NA,0.592,no,GO:0030198,0.704
RSCID.457769.81260,GSE12662,"Normal human bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time course",81,cell type,acute myeloid leukemia; tumorous; bone marrow,bone marrow; neutrophil; reference subject role,2708,NCI NIH HHS,0.624,yes,no,no,0.598,0.633,0.605,no,GO:1990904,0.529
RSCID.456407.19577,GSE12679,Laser capture microdissection of endothelial and neuronal cells from human dorsolateral prefrontal cortex,32,cell type,endothelial cell,Neuron,48,NA,0.822,no,no,no,NA,NA,0.518,no,GO:0006928,0.59
RSCID.458607.81209,GSE12720,Unique early gene expression patterns in adult to adult living donor liver grafts compared to deceased donor grafts,63,environmental history,donor; alive,donor; dead,2,NIDDK NIH HHS,0.978,no,no,no,0.713,0.979,1,no,GO:1901655,0.749
RSCID.445078.19607,GSE12764,Gene expression changes upon expression of activated versions of MEK1 and HRAS in MCF10A cells,11,treatment,Null Vector,HRas Vector,1270,NA,0.596,no,no,no,NA,NA,0.573,no,GO:0051240,0.515
RSCID.445112.81193,GSE12814,Identifying the molecular signature of the interstitial del(7q) subgroup of uterine leiomyomata using a paired analysis,22,organism part,7q; uterine fibroid; deletion,myometrium,223,NICHD NIH HHS,0.774,no,no,no,0.711,0.765,0.537,no,GO:0007267,0.533
RSCID.457114.77341,GSE12838,The Monocyte Advantage,44,timepoint,Day 3,Day 5,79,NA,0.858,no,no,no,NA,NA,0.603,no,GO:0006952,0.615
RSCID.458672.34701,GSE13059,Expression data from short-time cultured primary cells derived from colorectal adenocarcinoma,27,cell type,Colon Carcinoma; primary cell culture,Reference; reference subject role,115,NA,0.961,yes,no,no,NA,NA,0.949,no,GO:0031012,0.643
RSCID.446935.19894,GSE13073,MSCs Exposed to Keratinocyte Condition Medium,6,treatment,Conditioned Medium; keratinocyte,Growth medium; reference subject role,294,Intramural NIH HHS,0.811,yes,no,no,0.581,0.799,0.835,no,GO:0034097,0.551
RSCID.450004.68334,GSE13139,LOX-1-dependent transcriptional regulation after oxidized LDL (OxLDL) treatment of human aortic endothelial cells.,54,phenotype,LOX-1,GFP,13,NA,0.401,no,no,no,NA,NA,0.532,no,GO:0042995,0.588
RSCID.458730.19525,GSE13205,Skeletal muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure,21,disease,Sepsis syndrome,reference subject role,95,NA,0.79,no,no,no,NA,NA,0.703,no,GO:0003012,0.55
RSCID.459442.43890,GSE13309,Tobacco Smoke Induces Polycomb-mediated Repression of Dickkopf-1 in Lung Cancer Cells,24,cell line,A549,Calu-6,981,NA,0.825,no,no,no,NA,NA,0.855,no,GO:0009888,0.527
RSCID.459441.44144,GSE13314,Gene expression profiling of pulmonary MALT lymphoma,32,disease,MALT1 Tx: None,MALT1 Tx: API2-MALT1,1,NCI NIH HHS,0.991,no,no,no,0.865,0.992,NA,no,NA,NA
RSCID.456913.21067,GSE13355,Gene expression data of skin from psoriatic patients and normal controls,122,clinical history,Involved skin from cases,Normal Skin from controls,119,NCRR NIH HHS,0.91,yes,no,no,0.793,0.871,0.928,no,GO:0006955,0.608
RSCID.458697.82113,GSE13367,Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes...,56,cell type,Colonocytes,Biopsy,264,NA,0.938,no,no,no,NA,NA,0.955,no,GO:0031012,0.588
RSCID.457446.71665,GSE13400,Exposure of SKGT4 and HET-1A cell lines to deoxycholic acid (DCA),32,strain,HET-1A,SKGT4,949,NA,0.845,yes,no,no,NA,NA,0.867,no,GO:0009888,0.529
RSCID.457848.82151,GSE13487,Antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression,16,genotype,shBRAF; 2,reference subject role,10,NA,0.926,no,no,no,NA,NA,0.685,no,GO:0006954,0.643
RSCID.459093.20179,GSE13501,Subtype-specific peripheral blood gene expression profiles in recent onset JIA,70,disease,enthesitis-related arthritis,oligoarthritis,10,NA,0.999,no,yes,no,NA,NA,1,no,GO:0016577,0.642
RSCID.457007.77395,GSE13548,Expression data from human cancer cells treated with UPR modulators under ER stress conditions,42,timepoint,18h,15h,5,NA,0.913,no,no,no,NA,NA,0.622,no,GO:0019433,0.625
RSCID.448078.35224,GSE13564,Gene expression in the human prefrontal cortex during postnatal development,31,developmental stage,< 18 years; Human juvenile,< 3 years; Human infant,30,NA,0.843,no,no,no,NA,NA,0.586,no,GO:0040011,0.621
RSCID.457110.77411,GSE13637,Influenza virus infected HUVEC,21,genetic modification,pEGZ-transfected (empty vector),wild type genotype,4,NA,0.973,no,no,no,NA,NA,0.624,no,GO:0001666,0.746
RSCID.445421.82133,GSE13670,Gene expression data from S. aureus-exposed macrophages,30,treatment,Staphylococcus aureus,reference subject role,397,Intramural NIH HHS,0.765,yes,no,no,0.683,0.753,0.798,no,GO:0006952,0.58
RSCID.458972.34753,GSE13712,Differential gene expression of young and senescent HUVECs under static and laminar shear stress conditions,12,age,young,old,95,NA,0.892,no,no,no,NA,NA,0.751,no,GO:0034097,0.538
RSCID.440657.39482,GSE13732,CIS (multiple sclerosis) (case-control) (time-series),113,disease,Clinically isolated syndrome,Healthy control,13,NA,0.907,yes,no,no,NA,NA,NA,no,GO:0006952,0.73
RSCID.445940.19179,GSE13738,Human CD4+ memory T cells are preferential targets for bystander activation and apoptosis,8,cell type,directly activated; T cell,bystander activated; T cell,151,NA,0.874,no,no,no,NA,NA,0.639,no,GO:0051240,0.571
RSCID.445914.19316,GSE13762,"Comparative gene expression profile of 1,25-dihydroxyvitamin D3-treated human monocyte-derived dendritic cells",15,treatment,"1,25 dihydroxyvitamin D3; vitamin D",reference subject role; vehicle,185,NA,0.85,no,no,no,NA,NA,0.773,no,GO:0006955,0.565
RSCID.446249.18878,GSE13787,Frequent PTEN genomic alterations and activated PI3K pathway in basal-like breast cancer,23,disease,"Breast Carcinoma; ERBB2 [human] v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)",basal cell carcinoma; Breast Carcinoma,383,NA,0.8,no,no,no,NA,NA,NA,no,GO:0006629,0.534
RSCID.456680.40238,GSE13791,"Expression data from human primary fibroblasts, endothelial and smooth muscle cells infected with Trypanosoma cruzi",18,cell type,smooth muscle cell,endothelial cell,730,NIAID NIH HHS,0.863,yes,no,no,0.688,0.847,0.878,no,GO:0051270,0.54
RSCID.458711.19499,GSE13811,Analysis of gene expression response of CLL cells to co-culture with Nurse like cells,18,treatment,Fresh CLL Cells,Co-Cultured with NLC,15,NA,0.979,yes,no,no,NA,NA,0.784,no,GO:0030335,0.67
RSCID.457197.78496,GSE13818,Small molecule inhibitors of HIF-2a translation link its 5â€™-UTR Iron-Responsive Element (IRE) to oxygen sensing,6,treatment,medium,Compound_41,26,NCI NIH HHS,0.926,no,no,no,0.897,0.896,NA,no,GO:0030334,0.605
RSCID.445828.40235,GSE13828,Induced pluripotent stem cells from a spinal muscular atrophy patient,8,cell type,embryonic stem cell,pluripotent stem cell,3,NINDS NIH HHS,0.516,no,no,no,0.566,0.539,0.999,no,GO:0008270,0.826
RSCID.456750.20151,GSE13837,Adapted Boolean Network Models for Extracellular Matrix Formation,60,treatment,TGF stimulated,TNF stimulated,43,NA,0.946,yes,no,no,NA,NA,NA,no,GO:0034097,0.728
RSCID.458818.19170,GSE13887,Activation of mTOR controls the loss of TCR? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation,19,disease,untreated; Systemic lupus erythematosus,untreated; reference subject role,2,NIAID NIH HHS,0.954,no,no,no,0.862,0.966,0.566,no,GO:0006915,0.986
RSCID.456738.20105,GSE13896,Smoking-dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of COPD,58,clinical history,Smoking,Non smoking; reference subject role,6,NHLBI NIH HHS,0.965,no,no,no,0.841,0.977,0.583,no,GO:0006952,0.647
RSCID.459972.112479,GSE13904,"Expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum",85,disease,septic shock; 1 day,1 day; reference subject role,126,NIGMS NIH HHS,0.922,no,no,yes,0.986,0.952,0.986,yes,GO:0006955,0.581
RSCID.455545.113419,GSE13909,Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal,18,timepoint,before treatment,8 hours,37,NA,0.866,no,no,no,NA,NA,0.67,no,GO:0034097,0.651
RSCID.458775.18856,GSE13911,Expression data from primary gastric tumors (MSI and MSS) and adjacent normal samples,51,disease,Microsatellite Instability; stomach tumor,reference subject role,195,NA,0.892,yes,no,no,NA,NA,0.852,no,GO:0009888,0.533
RSCID.449248.77416,GSE13933,Trachea Epithelium as a â€œ Canaryâ€ for Cigarette Smoking-induced Biologic Phenotype of Small Airway Epithelium,54,phenotype,Smoker,reference subject role,62,NHLBI NIH HHS,0.794,no,no,no,0.739,0.773,0.595,no,GO:0016491,0.584
RSCID.456781.20016,GSE14001,PAX2: A Potential Biomarker for Low Malignant Potential Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas,13,clinical history,High grade serous ovarian carcinoma,Ovarian surface epithelia,1164,NCI NIH HHS,0.751,yes,no,no,0.737,0.742,0.752,no,GO:0030054,0.521
RSCID.457856.82020,GSE14062,MLL rearrangements in pediatric ALL and AML: MLL specific and lineage specific signatures,140,genotype,"Rearrangment; MLL [human] myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)",Without MLL rearrangment; wild type genotype,277,NA,0.743,no,no,no,NA,NA,0.602,no,GO:0030054,0.542
RSCID.454824.19639,GSE14245,Multiple Salivary Biomarkers for Early Detection of Pancreatic Cancer,24,disease,Pancreatic Cancer,reference subject role,5,NA,0.701,no,no,no,NA,NA,NA,no,GO:0046649,0.694
RSCID.447888.20987,GSE14315,Effects of demethylation on lung cancer cell lines,58,treatment,azacitidine; trichostatin A,reference substance role,762,NA,0.822,yes,no,no,NA,NA,0.831,no,GO:0006955,0.54
RSCID.449977.76522,GSE14333,Expression data from 290 primary colorectal cancers,290,sex,female,male,10,NCI NIH HHS,0.998,no,yes,no,0.774,0.9,1,no,GO:0016577,0.624
RSCID.456939.74002,GSE14334,Transcriptomic analysis of human lung development,6,developmental stage,133 dpc,110 dpc,34,NHLBI NIH HHS,0.913,no,no,no,0.786,0.898,0.562,no,GO:0006952,0.657
RSCID.458777.18820,GSE14386,Interferon beta-1a-induced changes in gene expression in PBMCs derived from CIS patients,30,treatment,IFNB-1a,reference subject role,3,NINDS NIH HHS,0.996,no,no,no,0.558,0.996,0.666,no,GO:0019221,0.988
RSCID.459523.67827,GSE14407,Ovarian Cancer gene expression profiling identifies the surface of the ovary as a stem cell niche,24,disease,ovarian carcinoma,reference subject role,646,NA,0.827,no,no,no,NA,NA,0.837,no,GO:0009888,0.525
RSCID.466795.123995,GSE14468,Gene expression profiling of CEBPA double and single mutant and CEBPA wild type AML.,526,sex,female,male,5,NA,0.999,no,yes,no,NA,NA,1,no,GO:0060765,0.666
RSCID.456585.19117,GSE14479,Genome-wide gene expression in CEBPA mutant and CEBPA silenced AML and in T-ALL,17,disease,Silenced AML,ALL,184,NIGMS NIH HHS,0.853,no,no,no,0.671,0.822,0.599,no,GO:0001775,0.549
RSCID.456449.17557,GSE14519,Expression data from multiple myeloma cells treated with arsenic,20,treatment,arsenic trioxide; arsenic oxides,reference subject role,46,NCI NIH HHS,0.737,no,no,no,0.735,0.743,NA,no,GO:0000785,0.575
RSCID.453347.99648,GSE14580,Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis,30,disease,ulcerative colitis,reference subject role,982,NA,0.841,yes,no,no,NA,NA,0.696,no,GO:0006955,0.557
RSCID.449147.75709,GSE14615,Microarray analyses of induction failure in T-ALL (COG study 9404),36,clinical history,complete continous remission,no response; induction failure,49,NCI NIH HHS,0.852,no,no,no,0.813,0.854,0.744,no,GO:0022402,0.617
RSCID.459521.77435,GSE14668,B-Cell Gene Signature with Massive Intrahepatic Production of Antibodies to Hepatitis B Core Antigen in HBV-Associated Acute Liver Failure,20,organism part,angioma; liver,reference subject role; liver,55,Intramural NIH HHS,0.836,no,no,no,0.573,0.776,0.613,no,GO:0006082,0.621
RSCID.456574.19262,GSE14680,Expression data from multiple myeloma cells overexpressing CS1 versus CS1 knockdown,10,cell line,OPM2,U266,459,NA,0.801,no,no,no,NA,NA,0.791,no,GO:0043067,0.532
RSCID.445615.19787,GSE14711,Parkinsonâ€™s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors,5,cell type,factor free; induced; pluripotent stem cell,fibroblast; reference subject role,3866,NCI NIH HHS,0.734,no,no,no,0.706,0.716,0.779,no,GO:0051240,0.518
RSCID.442055.75719,GSE14834.1,Characterization of B- and T-lineage ALL by Integrated Analysis of microRNA and mRNA Expression Profiles - GPL570,12,genetic modification,BCR/ABL,normal,4,NA,0.447,no,no,no,NA,NA,0.467,no,GO:0021987,0.624
RSCID.456636.19143,GSE14844,Reliability and stability of individual differences in gene expression,19,timepoint,10 months,Day 1,12,NA,0.729,no,no,no,NA,NA,0.588,no,GO:0051249,0.643
RSCID.448597.35108,GSE14858,Gene exprssion profile classification predicts clinical outcome in juvenile myelomonocytic leukemia,40,disease,dislike; acute myeloid leukemia,like; acute myeloid leukemia,3,NA,0.938,no,no,no,NA,NA,0.746,no,GO:0031463,0.665
RSCID.459525.74370,GSE14879,"Gene expression study of anaplastic large cell lymphomas: cellular origin, pathogenesis and relation to Hodgkin lymphoma",11,cell type,cALCL,tcr-cHL,131,NA,0.863,no,no,no,NA,NA,NA,no,GO:0006955,0.572
RSCID.459166.65062,GSE14880,Differentation in neuroblastomas,34,disease,Neuroblastoma,Ganglioneuroblastoma,6,NA,0.723,no,no,no,NA,NA,0.499,no,GO:0043604,0.655
RSCID.460473.18720,GSE14901,Limb immobilization induces a coordinate down-regulation of mitochondrial and other metabolic pathways in men and women,72,sex,female,male,14,NA,0.842,no,no,no,NA,NA,0.928,no,GO:0016577,0.583
RSCID.456621.19175,GSE14905,Type I Interferon: Potential Therapeutic Target for Psoriasis?,54,disease,Lesion Skin,Normal Skin,168,NA,0.914,yes,no,no,NA,NA,0.791,no,GO:0006952,0.561
RSCID.456809.19954,GSE14924,Characterisation of gene expression changes in T cells from patients presenting with AML compared with healthy T cells,41,cell type,cytotoxic T cell,helper T cell,53,NCI NIH HHS,0.909,no,no,no,0.886,0.921,0.669,no,GO:0006955,0.651
RSCID.459035.34711,GSE14926,Analysis of the impact of the method of cell selection on the gene expression profile of human CD4 and CD8 T cells,19,treatment,negative,positive,32,NA,0.941,yes,no,no,NA,NA,0.548,no,GO:0006955,0.69
RSCID.449018.74109,GSE14973,Antileukemic activity of valproic acid in chronic lymphocytic leukemia cells defined by microarray analysis,28,treatment,valproic acid,reference subject role,20,NA,0.738,no,no,no,NA,NA,0.568,no,GO:0033043,0.575
RSCID.463702.119185,GSE14986,Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common clonal drug-resistant progenitor,30,treatment,fulvestrant,reference substance role,166,NCI NIH HHS,0.791,no,no,no,0.752,0.772,0.764,no,GO:0022402,0.629
RSCID.459524.73598,GSE15013,Expression of HOXB genes is significantly different in acute myeloid leukemia with a partial tandem duplication of MLL vs. a MLL translocation: a cross-laboratory study,25,genetic modification,MLL translocation; acute myeloid leukemia,MLL partial tandem duplication; acute myeloid leukemia,55,NA,0.882,no,no,no,NA,NA,0.59,no,GO:0044877,0.559
RSCID.458758.19280,GSE15132,Riboflavin depletion impairs cell proliferation in intestinal cells: Identification of mechanisms and consequences,18,treatment,Riboflavin Deficiency,reference subject role,40,NA,0.883,no,no,no,NA,NA,NA,no,GO:0022603,0.618
RSCID.457883.86354,GSE15148,Human induced pluripotent stem cells free of exogenous DNA are derived with episomal vectors,26,cell type,embryonic stem cell,induced; pluripotent stem cell,39,NIGMS NIH HHS,0.829,no,no,no,0.642,0.775,0.533,no,GO:0051094,0.57
RSCID.441812.40037,GSE15209,Expression data from human foetal neural stem (NS) cell lines and human glioma neural stem (GNS) cell lines,9,cell type,Glioblastoma,oligoastrocytoma,51,NA,0.894,no,no,no,NA,NA,0.7,no,GO:0043067,0.584
RSCID.457881.86315,GSE15396,"Peripheral blood mononuclear, DU145, and HCT116 cells treated with a CDK inhibitor",111,cell type,HCT116 tumor cell,mononuclear cell,2337,NA,0.793,yes,no,no,NA,NA,0.77,no,GO:0006955,0.539
RSCID.448625.76593,GSE15434,Gene expression profiling in AML with normal karyotype: A multicenter study investigating molecular markers in 251 cases,251,sex,female,male,8,NA,0.999,no,yes,no,NA,NA,1,no,GO:0060765,0.583
RSCID.457566.71759,GSE15455,GEMINI (Gastric Encyclopedia of Molecular Interactions and Nodes for Intervention) Phases A-C,6,cell line,MKN74,AGS,773,NA,0.808,no,no,no,NA,NA,0.816,no,GO:0009888,0.535
RSCID.456663.76004,GSE15471,Whole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma,78,disease,Pancreatic Ductal Adenocarcinoma,reference subject role,216,NA,0.914,yes,no,no,NA,NA,0.806,no,GO:0030198,0.585
RSCID.459526.74360,GSE15490,Sequential gene expression profiling in CLL during treatment,20,treatment,after fludarabine+cyclophosphamide,before rituximab,32,NA,0.903,no,no,no,NA,NA,0.647,no,GO:0006928,0.6
RSCID.459971.111644,GSE15605,Transcriptome profiling identifies HMGA2 as a novel gene in melanoma progression,62,disease,Primary Melanoma,skin of body,743,NCI NIH HHS,0.764,yes,no,no,0.768,0.771,0.788,no,GO:0009888,0.535
RSCID.458531.81916,GSE15636,"L. acidophilus NCFMâ„¢, B. lactis 420, L. salivarius Ls-33  and E. coli O157:H7 effect on intestinal epithelial cells",20,treatment,24 hours; Cell-free supernatant,Coculture; 8 hours,20,NA,0.829,no,no,no,NA,NA,0.493,no,GO:1901700,0.603
RSCID.457345.74192,GSE15824,Gene expression profiling of human gliomas and human glioblastoma cell lines,37,cell line,LN018,N/A,4359,NA,0.699,yes,no,no,NA,NA,0.681,no,GO:0007049,0.522
RSCID.457066.80958,GSE15935,Expression data from 'naÃ¯ve' and HVC-replicon containing Huh7 cells (Clone A cells),82,cell line,Huh7,Clone A,40,NA,0.838,no,no,no,NA,NA,0.524,no,GO:0010562,0.564
RSCID.434730.40204,GSE15947,"Time course of 1,25(OH)2D treated RWPE1 cells.",24,treatment,vehicle,"1,25-dihydroxyvitamin D3",26,NCI NIH HHS,0.817,no,no,no,0.858,0.822,0.52,no,GO:0009888,0.597
RSCID.461414.81924,GSE16015,AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping features,97,genotype,"2-positive mutation; NPM1 [human] nucleophosmin (nucleolar phosphoprotein B23, numatrin)",wild type genotype,22,NA,0.928,no,no,no,NA,NA,NA,no,GO:0042592,0.639
RSCID.450880.75757,GSE16020,Patients affected with autosomal dominant monocytopenia with increased susceptibility to mycobacterial infection,20,disease,polymorphonuclear leukocytes,reference subject role,104,Intramural NIH HHS,0.742,no,no,no,0.582,0.738,NA,no,GO:0051240,0.555
RSCID.446743.19975,GSE16054,Transient expression of misfolded surfactant protein C,6,genetic modification,Exon4 deletion; SFTPC [human] surfactant protein C,wild type genotype,4,NA,0.786,no,no,no,NA,NA,0.614,no,GO:0031904,0.624
RSCID.459505.76612,GSE16134,Bacterial Correlates of Gingival Gene Expression,310,treatment,gingival disease,reference subject role,11,NA,0.937,no,no,no,NA,NA,0.917,no,GO:0050864,0.623
RSCID.455526.75948,GSE16157,Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions,38,phenotype,supernatant: no,supernatant: yes,15,NA,0.648,no,no,no,NA,NA,0.512,no,GO:0071363,0.616
RSCID.459005.19948,GSE16176,Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls,14,genotype,euploid (control group),Down syndrome,146,NICHD NIH HHS,0.61,no,no,no,0.542,0.61,0.512,no,GO:0030054,0.588
RSCID.459359.40029,GSE16191,EGR4 is a master gene responsible for fertility in cryptorchidism,18,clinical history,unilateral,reference subject role,4,NA,0.728,no,no,no,NA,NA,0.487,no,GO:0001533,0.624
RSCID.457048.64905,GSE16193,Interfering with Proximal TLR4 to NF-kappaB Signal Transduction in Human Monocytes,10,treatment,carbon monoxide; Lipopolysaccharide,reference subject role,20,Intramural NIH HHS,0.977,yes,no,no,0.84,0.932,0.942,no,GO:0043207,0.699
RSCID.459970.112467,GSE16214,Expression data from relapsing-remitting MS samples,176,treatment,interferon beta,reference substance role,2,NIAID NIH HHS,0.998,no,no,no,0.98,0.995,1,no,GO:0046825,0.749
RSCID.458976.20012,GSE16236,Transcriptional profiling of bone marrow cells of MDS patients,7,cell type,Lymphoid cell,Lymphoid cell; reference subject role,378,NA,0.674,yes,no,no,NA,NA,NA,no,GO:0061024,0.52
RSCID.458523.81873,GSE16237,Expression data of human neuroblastoma tissue samples,51,disease staging,Deceased; died of disease,alive,6,NA,0.833,no,no,no,NA,NA,0.622,no,GO:0006952,0.813
RSCID.456975.77453,GSE16363,"Microarray Analysis of Lymphatic Tissue Reveals Stage-Specific, Gene-Expression Signatures in HIV-1 Infection",28,disease staging,asymptomatic AIDS,uninfected; reference subject role,29,NIAID NIH HHS,0.957,no,no,no,0.82,0.954,0.687,no,GO:0006955,0.634
RSCID.457045.64911,GSE16395,Cell-Specific Gene Expression in Langerhans Cell Histiocytosis,25,organism part,CD207+; Langerhans cell histiocytosis lesion,CD207+; skin,583,NCI NIH HHS,0.831,no,no,no,0.83,0.833,0.841,no,GO:0009888,0.559
RSCID.460482.17938,GSE1643,Normal Variance of Gene Expression in the Human Lung,40,organism part,upper lobe of lung,lower lobe of lung,3,NHLBI NIH HHS,0.905,no,no,no,0.732,0.845,0.652,no,GO:0071495,0.812
RSCID.459016.19931,GSE16450,Human BE(2)-C neuronal responses to type I IFN stimulation,18,cell type,immature,all-trans-retinoic acid; mature,152,NA,0.875,no,no,no,NA,NA,0.891,no,GO:0009888,0.568
RSCID.447533.20188,GSE16451,Human BE(2)-C neuronal responses to WEEV infection,8,cell type,mature,all-trans-retinoic acid; immature,305,NA,0.809,no,no,no,NA,NA,0.689,no,GO:0045595,0.549
RSCID.457308.74395,GSE16455,Indolent MCL identified by genomic and gene expression profiling,24,disease,chronic lymphocytic leukemia,follicular lymphoma,198,NA,0.8,no,no,no,NA,NA,0.833,no,GO:1901700,0.531
RSCID.458004.86550,GSE16461,Gene expression profile in CD4+ and CD8+ T cells from identical twins discordant for Multiple sclerosis,16,cell type,CD8+ T cell,CD4+ T cell,149,NA,0.911,yes,no,no,NA,NA,0.954,no,GO:0006955,0.682
RSCID.465253.122032,GSE16478,Integrated bioinformatic and wet-lab approach to identify potential oncogenic networks in neuroblastoma: MYCN,28,genotype,"Overexpression; MYCN [human] v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)",wild type genotype,9559,NCI NIH HHS,0.568,yes,no,no,0.56,0.564,0.5,no,GO:0007049,0.521
RSCID.458965.19988,GSE16515,Expression data from Mayo Clinic Pancreatic Tumor and Normal samples,52,cell type,Normal Tissue,Tumour Tissue,205,NIGMS NIH HHS,0.865,yes,no,no,0.631,0.811,0.843,no,GO:0009888,0.544
RSCID.456670.74523,GSE16524,Expression data from skin fibroblasts derived from Setleis Syndrome patients and normal controls,8,disease,Setleis Syndrome,reference subject role,1,NA,0.918,no,no,no,NA,NA,0.496,no,GO:0005201,0.998
RSCID.446157.19850,GSE16538,Genome-wide gene expression profile analysis in pulmonary sarcoidosis,12,disease,"Sarcoidosis, Pulmonary",reference subject role,11,NHLBI NIH HHS,0.919,no,no,no,0.805,0.908,0.636,no,GO:0006955,0.753
RSCID.459601.71706,GSE16581,Genomic landscape of meningiomas: gene expression,68,sex,male,female,8,NINDS NIH HHS,0.999,no,yes,no,0.768,0.997,1,no,GO:0051704,0.647
RSCID.457872.86439,GSE16648,Networking of differentially expressed genes in human cancer cell lines resistant to methotrexate,42,phenotype,methotrexate; sensitive toward,methotrexate; resistant to,152,NA,0.816,no,no,no,NA,NA,0.685,no,GO:0042995,0.537
RSCID.450078.67504,GSE16715,Expression profiling in Williams-Beuren Syndrome patient fibroblast cell lines,17,disease,Williams syndrome,reference subject role,29,NA,0.94,no,no,no,NA,NA,0.665,no,GO:0031012,0.669
RSCID.458864.65057,GSE16728,Characterization of whole blood gene expression profiles in sickle-cell disease patients using globin mRNA reduction,30,disease,Sickle Cell Anemia,reference subject role,228,NA,0.648,yes,no,no,NA,NA,0.499,no,GO:0070647,0.525
RSCID.446894.19882,GSE16755,Gene expression in macrophages treated with IFNalpha,6,treatment,IFNa Treated,reference subject role,109,Intramural NIH HHS,0.865,no,no,no,0.857,0.846,0.914,no,GO:0034097,0.611
RSCID.448911.75984,GSE16797,Clinical score and gene profiling patterns identify Kawasaki disease patients who may benefit from methylprednisolone,34,medical procedure,Post-treatment,pre-treatment,1,NA,0.795,no,no,no,NA,NA,0.467,no,GO:0042571,0.5
RSCID.449891.67595,GSE16837,Gene expression data from S. aureus-exposed neutrophils,36,treatment,11490; Staphylococcus aureus,reference subject role,291,Intramural NIH HHS,0.695,no,no,no,0.584,0.68,0.547,no,GO:0045944,0.532
RSCID.459003.19896,GSE16844,Integrated pathways for neutrophil recruitment and inflammation in leprosy,13,disease,erythema nodosum leprosum,"Leprosy, Lepromatous; reference subject role",87,NIAID NIH HHS,0.907,no,no,no,0.683,0.895,NA,no,GO:0006952,0.566
RSCID.457174.78522,GSE16870,HeLa cells treated with V-ATPase inhibitors or with desoxyferramine compared to HeLa in DMSO or medium with low LDL,24,treatment,bafilomycin,reference subject role,23,NCRR NIH HHS,0.849,no,no,no,0.55,0.774,0.595,no,GO:0044711,0.678
RSCID.449293.76034,GSE17032,Expression data from human fibroblasts,36,organism part,lung,skin of body,406,NCI NIH HHS,0.85,no,no,no,0.82,0.832,0.882,no,GO:0051240,0.546
RSCID.457316.76763,GSE17183,Hepatic gene expression before and during interferon and ribavirin combination therapy,108,treatment,ribavirin; interferon,baseline participant role,1,NA,0.641,no,no,no,NA,NA,0.958,no,GO:0042571,0.5
RSCID.452201.71799,GSE17372,Molecular Classification of AIDS-Related Lymphomas (HIV+ and HIV- cases),124,disease,GCB; HIV-lymphoma,HIV+ lymphoma,18552,NCI NIH HHS,0.551,yes,no,no,0.575,0.561,0.656,no,GO:0030054,0.524
RSCID.459113.20236,GSE17385,Gene expression profiling from MM1.S cells with control or beta-catenin knockdown.,6,genetic modification,"knock-down; CTNNB1 [human] catenin (cadherin-associated protein), beta 1, 88kDa",reference subject role,109,NA,0.884,no,no,no,NA,NA,0.595,no,GO:0007049,0.663
RSCID.434828.73933,GSE17400,Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection,18,timepoint,24 hrs post-infection,12 hrs post-infection,2,NIAID NIH HHS,0.96,no,no,no,0.922,0.978,0.75,no,GO:1903047,0.982
RSCID.459294.93997,GSE17548,Expression data from cirrhosis and HCC tissue samples,30,organism part,hepatocellular carcinoma,cirrhotic liver tissue,43,NA,0.894,no,no,no,NA,NA,0.862,no,GO:0007155,0.562
RSCID.446534.20142,GSE17624,Expression data from human Ishikawa cells treated with Bisphenol A,40,timepoint,48 hours,8 H,91,NA,0.602,no,no,no,NA,NA,0.522,no,GO:0051050,0.527
RSCID.457144.39847,GSE17708,Time Course of TGF-beta treatment of A549 lung adenocarcinoma cell line,26,genetic modification,TGF-beta Receptor Type II Tumor-Suppressor Gene Inactivation,reference substance role,600,NCI NIH HHS,0.844,no,no,no,0.808,0.818,0.86,no,GO:0040012,0.548
RSCID.459452.40010,GSE17714,11 Neuroblastoma cell lines under normoxic and hypoxic conditions,22,disease,normoxia,hypoxia,3,NA,0.949,no,no,no,NA,NA,NA,no,GO:0097193,0.83
RSCID.459092.20192,GSE17743,Gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression,18,genotype,mutant; KIT [human] v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,wild type genotype,57,NA,0.857,no,no,no,NA,NA,0.767,no,GO:0051240,0.565
RSCID.460153.116891,GSE17800,Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy,48,sex,male,female,8,NA,0.974,no,yes,no,NA,NA,0.9,no,GO:0060765,0.583
RSCID.457695.82469,GSE17906,Gene expression down-regulation in prostate tumor-associated stromal cells involves organ-specific genes,10,disease,CD26+; prostate cancer,prostate cancer; normal,1712,NIGMS NIH HHS,0.77,yes,no,no,0.602,0.758,0.738,no,GO:0043067,0.521
RSCID.459543.67847,GSE17913,Effects of Cigarette Smoke on the Human Oral Mucosal Transcriptome,79,molecular entity,Nicotine,reference subject role,1,NCI NIH HHS,0.999,no,no,no,0.995,0.998,1,no,GO:0046466,0.999
RSCID.466645.123574,GSE17951,Gene expression analysis of prostate cancer samples using Affymetrix U133Plus2 array,154,disease,prostate cancer,reference subject role,228,NCI NIH HHS,0.79,no,no,no,0.737,0.785,0.518,no,GO:0034220,0.536
RSCID.459390.64897,GSE18018,Multilineage dysplasia and AML with mutated nucleophosmin,48,disease,multilineage dysplasia,reference subject role,2,NA,0.986,no,no,no,NA,NA,1,no,GO:0030141,0.994
RSCID.459545.77486,GSE18090,Gene Expression Profiling During Early Acute Febrile Stage of Dengue Infection Can Predict The Disease Outcome,18,disease,dengue hemorrhagic fever,reference subject role,7,NIAID NIH HHS,0.996,no,no,no,0.949,0.994,0.889,no,GO:0003682,0.792
RSCID.458551.82573,GSE18096,Identifying the molecular signature of the t(12;14) subgroup of uterine leiomyomata using a paired analysis,18,disease,Non-t(12;14); uterine fibroid,normal; myometrium,74,NICHD NIH HHS,0.906,no,no,no,0.924,0.9,NA,no,GO:0007267,0.55
RSCID.432574.76065,GSE18105,Stage II and stage III colorectal cancer,111,treatment,homogenized tissue,Laser Capture Microdissection (LCM),50,NA,0.757,no,no,no,NA,NA,0.516,no,GO:0006955,0.553
RSCID.441361.89123,GSE18123.1,Blood gene expression signatures distinguish autism spectrum disorders from controls - GPL570,64,disease,autism,reference subject role,22,NA,0.678,no,no,no,NA,NA,0.538,no,GO:0006955,0.612
RSCID.457381.87218,GSE18206,Analysis of human in vivo irritated epidermis: differential profiles induced by sodium lauryl sulphate and nonanoic acid,24,timepoint,0 hours,11 days,3,NA,0.9,no,no,no,NA,NA,0.749,no,GO:0001533,0.833
RSCID.459218.88550,GSE18271,Analysis of TALE homeobox genes in neuroblastic tumors: ganglioneuroblastoma and ganglioneuroma,22,disease,Ganglioneuroma,Ganglioneuroblastoma,288,NA,0.832,no,no,no,NA,NA,0.742,no,GO:0007267,0.543
RSCID.457459.71573,GSE18373,Expression data of HUVEC and OVCA429 with recombinant MAGP2,12,cell type,OVCA429,endothelial cell of umbilical vein,1392,NCI NIH HHS,0.815,no,no,no,0.795,0.801,0.831,no,GO:0051270,0.53
RSCID.457457.71569,GSE18520,Whole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas,63,disease,papillary serous ovarian adenocarcinoma,reference subject role,584,NCI NIH HHS,0.893,no,no,no,0.875,0.866,0.917,no,GO:0009888,0.531
RSCID.457448.71652,GSE18552,CDK inhibitors and flavopiridol profiling on A2780 and MCF7 cells,35,cell type,Adenocarcinoma; female gonad,Adenocarcinoma; mammary gland,1841,NA,0.787,no,no,no,NA,NA,0.823,no,GO:0009888,0.527
RSCID.459546.77481,GSE18608,Transcriptional Profiling of CD133+ Cells in Coronary Artery Disease and Effects of Exercise on Gene Expression,14,disease,before exercise; Coronary heart disease,reference subject role,10,Intramural NIH HHS,0.754,no,no,no,0.497,0.738,0.601,no,GO:0031294,0.598
RSCID.437543.76074,GSE18668,Differentiation of NUT midline carcinoma by epigenomic reprogramming,20,cell line,NMC cell line TC-797,NMC cell line PER-403,1705,NCI NIH HHS,0.711,no,no,no,0.703,0.705,0.735,no,GO:0051240,0.518
RSCID.459969.99867,GSE18670,Pancreatic cancer circulating tumor cells express a cell motility gene signature that predicts survival after surgery,12,cell type,original tumor,circulating tumor cells,3473,NA,0.742,no,no,no,NA,NA,0.718,no,GO:0051270,0.516
RSCID.459535.71372,GSE18781,Gene Expression in Inflammatory Diseases,43,disease,Spondylarthropathies,reference subject role,4,NA,1,no,yes,no,NA,NA,1,no,GO:0060765,0.666
RSCID.441086.77499,GSE18791,Antiviral response dictated by choreographed cascade of transcription factors,57,disease,Newcastle disease,reference subject role,183,NA,0.86,no,no,no,NA,NA,0.934,no,GO:0006952,0.663
RSCID.457029.40032,GSE18811,Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium,31,developmental stage,late embryo,Adult,152,Intramural NIH HHS,0.879,no,no,no,0.568,0.85,0.889,no,GO:0030198,0.554
RSCID.459302.73619,GSE18842,Gene expression analysis of human lung cancer and control samples,91,disease,non-small cell lung carcinoma,reference subject role,698,NA,0.895,no,no,no,NA,NA,0.837,no,GO:0009888,0.544
RSCID.457361.71355,GSE18864,Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients,84,cell type,reference tumor,pre-treatment tumor,25,NCI NIH HHS,0.962,yes,no,no,0.931,0.917,NA,no,GO:0031012,0.751
RSCID.459539.71189,GSE18913,siRNA-mediated Egr-3 knockdown in VEGF-treated HUVEC,21,treatment,siRNA; EGR3 [human] early growth response 3,reference subject role,7,NHLBI NIH HHS,0.852,no,no,no,0.659,0.841,0.497,no,GO:0034097,0.698
RSCID.449023.40050,GSE18995,Expression data from donor lungs of cardiac death and brain death donors,35,timepoint,post-transplant,pre-transplant,150,NA,0.814,yes,no,no,NA,NA,0.599,no,GO:0006952,0.592
RSCID.457155.77604,GSE19067,Molecular signatures in natural-killer (NK) cell lymphoma,20,cell type,NK/T lymphoma,Blastic NK-cell lymphoma,280,NCI NIH HHS,0.724,no,no,no,0.702,0.714,NA,no,GO:0022008,0.528
RSCID.457234.77189,GSE19069,Molecular signatures in peripheral T-cell lymphoma (PTCL),139,timepoint,n/a,0h; resting,84,NCI NIH HHS,0.768,no,no,no,0.662,0.736,0.5,no,GO:0006955,0.541
RSCID.459490.69619,GSE19188,Expression data for early stage NSCLC,110,disease,Squamous cell carcinoma,reference subject role,256,NA,0.918,no,no,no,NA,NA,0.983,no,GO:0006928,0.553
RSCID.463677.117864,GSE19234,Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.,44,sex,male,female,4,NCI NIH HHS,1,no,yes,no,0.999,0.999,1,no,GO:0060765,0.666
RSCID.456952.76137,GSE19293,In-transit extremity melanoma II,40,phenotype,response: CR,response: PD,6,NA,0.873,no,no,no,NA,NA,0.651,no,GO:0030234,0.645
RSCID.448403.34937,GSE19332,Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS),10,genotype,mutant; CHMP2B [human] chromatin modifying protein 2B,wild type,4,NA,0.505,no,no,no,NA,NA,0.74,no,GO:0010907,0.624
RSCID.459481.68897,GSE19352,Activation of phosphatidylcholine-cycle enzymes in human epithelial ovarian cancer cells,21,cell type,ovarian carcinoma,IGROV1,988,NCI NIH HHS,0.76,no,no,no,0.739,0.744,0.78,no,GO:0045595,0.524
RSCID.457237.69631,GSE19383,Altered gene expression in normal breast and ovarian epithelial cells from BRCA1 and BRCA2 mutation carriers,36,organism part,epithelial cell; breast,epithelial cell; female gonad,1234,NCI NIH HHS,0.829,no,no,no,0.833,0.823,0.87,no,GO:0009888,0.542
RSCID.459968.102689,GSE19404,Gene expression analysis of primitive neuroectodermal tumors,14,disease,primitive neuroectodermal tumor,reference subject role,144,NA,0.638,no,no,no,NA,NA,0.515,no,GO:0006396,0.545
RSCID.459480.70430,GSE19407,Smoking-induced Wnt pathway downregulation,24,phenotype,Non smoking,Smoking,28,NHLBI NIH HHS,0.881,no,no,no,0.919,0.876,0.738,no,GO:0016491,0.618
RSCID.455188.111105,GSE19429,Expression data from bone marrow CD34+ cells of MDS patients and healthy controls,200,disease,CD34+ cells; Myelodysplastic syndrome,CD34+ cells; reference subject role,21,NA,0.918,no,no,no,NA,NA,0.522,no,GO:0006955,0.705
RSCID.427193.69941,GSE19475,Gene expression data from infants (<1 year of age) diagnosed with Acute Lymphoblastic Leukemia (ALL),72,sex,female,male,6,NA,1,no,yes,no,NA,NA,1,no,GO:0060765,0.599
RSCID.450395.70157,GSE19577,"MLL partner genes confer distinct biological and clinical signatures of pediatric AML, an AIEOP study",21,genotype,AF6,AF10,33,NA,0.813,no,no,no,NA,NA,0.553,no,GO:0099503,0.556
RSCID.457207.76907,GSE19615,Integrated genomic and function characterization of the 8q22 gain,115,organism part,ER: pos,ER: neg,97,NCI NIH HHS,0.904,no,no,no,0.885,0.88,0.69,no,GO:0006928,0.552
RSCID.457225.68785,GSE19639,Hyperactivation of PI3K promotes escape from hormone dependence in estrogen receptor-positive breast cancer,24,treatment,lted: yes,reference subject role,106,NCI NIH HHS,0.873,no,no,no,0.824,0.854,0.565,no,GO:0006952,0.601
RSCID.457227.70892,GSE19650,Expression data from epithelial cells during the process of multistep pancreatic carcinogenesis,13,disease staging,pancreatic intraductal papillary-mucinous adenoma,reference subject role,802,NA,0.861,no,no,no,NA,NA,0.863,no,GO:0031012,0.533
RSCID.459474.69745,GSE19665,Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma,20,cell type,cancer,non-cancerous; reference subject role,363,NA,0.891,no,no,no,NA,NA,0.886,no,GO:0006955,0.543
RSCID.457231.70322,GSE19667,Threshold of Biologic Response of the Small Airway Epithelium to Low Levels of Tobacco Smoke,21,phenotype,Non smoking,symptomatic smoker,17,NCRR NIH HHS,0.927,no,no,no,0.791,0.931,0.623,no,GO:0016491,0.609
RSCID.459462.70494,GSE19728,Expression data from different grades (WHO) of astrocytomas (ACM),21,disease,Astrocytoma,healthy control,592,NA,0.816,no,no,no,NA,NA,0.847,no,GO:0097458,0.539
RSCID.449893.67548,GSE19743,A large-scale clinical study of gene expression response to severe burn injury,120,clinical history,mid; Burn injury,reference subject role,561,NIGMS NIH HHS,0.768,yes,no,no,0.687,0.776,0.689,yes,GO:0006955,0.548
RSCID.457217.68788,GSE19804,Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan,120,disease,lung carcinoma,reference subject role,455,NA,0.912,no,no,no,NA,NA,0.96,no,GO:0006928,0.544
RSCID.459463.68786,GSE19826,Expression data from gastric cancer,27,cell type,Stomach Carcinoma,reference subject role,116,NA,0.837,no,no,no,NA,NA,0.877,no,GO:0042592,0.549
RSCID.465316.121216,GSE19860,Prediction of response to FOLFOX,29,phenotype,FOLFOX6; sensitive toward,FOLFOX6; resistant to,1,NA,0.944,no,no,no,NA,NA,NA,no,GO:0006656,0.999
RSCID.459967.110965,GSE19864,"Gene expression profiles after RNAi-mediated suppression of RB, p107 or p130 in growing, quiescent or ras-induced senescent IMR90 cells",22,growth condition,growing,ras-senescent,121,NA,0.937,yes,no,no,NA,NA,NA,no,GO:0007049,0.646
RSCID.457358.68354,GSE19902,Comparative expression profiles of human embryonic stem cells among different feeders and conditioned media,4,treatment,feeder-free Matrigel in T3HDF-conditioned medium,MEF feeder,206,NA,0.838,no,no,no,NA,NA,0.554,no,GO:1903507,0.578
RSCID.459334.64935,GSE19982,Gene expression discriminates chromophobe renal cell carcinoma and oncocytoma,30,disease,oncocytoma of kidney,classic variant of chromophobe renal cell carcinoma,32,NA,0.864,no,no,no,NA,NA,0.583,no,GO:0022857,0.575
RSCID.461547.72413,GSE20124,Transcriptome analysis of human Whartonâ€™s jelly stem cells: in-house analysis,8,timepoint,passage 20,passage 3,396,NA,0.874,no,no,no,NA,NA,0.9,no,GO:0051270,0.541
RSCID.461582.72433,GSE20125,Transcriptome analysis of human Whartonâ€™s jelly stem cells: meta-analysis,18,cell type,mesenchymal stem cell of Wharton's jelly,Detroit 551 cell; fibroblast,312,NA,0.862,yes,no,no,NA,NA,0.876,no,GO:0040011,0.542
RSCID.460597.34061,GSE20141,Expression analysis of laser-dissected SNpc neurons in Parkinson's disease,18,disease,Parkinson's disease,reference subject role,542,NINDS NIH HHS,0.513,no,no,no,0.492,0.51,0.501,no,GO:0006955,0.518
RSCID.459338.64884,GSE20196,Gene expression profile of poorly differentiated synovial sarcoma,26,disease,monophasic sarcoma of the synovium,poorly differentiated,112,NA,0.9,no,no,no,NA,NA,0.764,no,GO:0040011,0.589
RSCID.459496.68548,GSE20211,LMP-420: a novel purine nucleoside analogue with potent cytotoxic effects for chronic lymphocytic leukemia cells,26,treatment,LMP-420,reference subject role,3,NA,0.993,no,no,no,NA,NA,0.999,no,GO:0048646,0.822
RSCID.450664.68843,GSE20266,Salivary Transcriptomic and Proteomic Biomarkers for Breast Cancer Detection,20,disease,Breast Carcinoma,reference subject role,136,NCI NIH HHS,0.511,no,no,no,0.515,0.518,0.534,no,GO:0006511,0.533
RSCID.457297.68917,GSE20436,Expression data from Gambian children with and without the clinical signs of active trachoma: U133 Plus2.0 array,60,disease,Chlamydia trachomatis infectious disease,reference subject role,67,NA,0.889,no,no,no,NA,NA,0.531,no,GO:1901700,0.58
RSCID.459439.96343,GSE20489,Microarray characterization of gene expression changes in blood during acute ethanol exposure,54,treatment,alcohol,reference subject role,5615,NA,0.545,no,no,no,NA,NA,0.536,no,GO:2000113,0.508
RSCID.457288.69684,GSE20505,Expression data from CD34+ hematopoietic progenitor cells,18,treatment,British,French,4,NA,0.942,no,no,no,NA,NA,0.83,no,GO:0044057,0.865
RSCID.459499.70508,GSE20538,Gene expression profiles of fibroblasts from MCT8 patients,20,genetic modification,"SLC16A2 [human] solute carrier family 16, member 2 (monocarboxylic acid transporter 8)",reference subject role,4,NA,0.883,no,no,no,NA,NA,NA,no,GO:0008047,0.739
RSCID.457260.70276,GSE20667,The Notch/Hes1 pathway sustains NF-kB activation through CYLD repression in T cell leukemia,20,treatment,IKK? Nemo binding domain (NBD) inhibitory peptide,reference subject role,2,NCI NIH HHS,0.944,no,no,no,0.9,0.944,0.75,no,GO:0033006,0.749
RSCID.457200.65193,GSE20854,EGFR Isoforms and Gene Regulation in Human Endometrial Cancer Cells,24,cell line,Ishikawa,Hec50co,1062,NCI NIH HHS,0.812,yes,no,no,0.798,0.795,0.846,no,GO:0051270,0.526
RSCID.457264.71423,GSE20916,Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data,145,block,macro,micro,563,NA,0.678,yes,no,no,NA,NA,0.563,no,GO:0030054,0.551
RSCID.450568.70564,GSE20948,The Effect of Hepatitis C Virus Infection on Host Gene Expression,28,treatment,Mock infected,JFH-1 infected,3,NA,0.979,no,no,no,NA,NA,0.666,no,GO:0044711,0.807
RSCID.459305.76184,GSE21029,"The lymph node microenvironment promotes B-cell receptor signaling, NF-?B activation, and tumor proliferation in chronic lymphocytic leukemia (CLL)",45,organism part,Peripheral blood cell,bone marrow,4,Intramural NIH HHS,0.987,no,no,no,0.724,0.978,1,no,GO:0031406,0.831
RSCID.459023.82673,GSE2125,isolated alveolar macrophages,30,individual,macrophage; status asthmaticus,Smoking; macrophage,20,NHLBI NIH HHS,0.932,no,no,no,0.677,0.907,NA,no,GO:0030334,0.616
RSCID.458423.95613,GSE21270,Genome-wide screening of temporal responsive genes induced by a low concentration of the carcinogen N-methyl-N'-nitro-N-nitrosoguanidine in a normal human cell line,18,treatment,dimethyl sulfoxide,N-methyl-N'-nitro-N-nitrosoguanidine,6,NA,0.933,no,no,no,NA,NA,0.799,no,GO:1902893,0.583
RSCID.449124.76188,GSE21293,"Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer",35,phenotype,invasive: No,invasive: Yes,185,NIDDK NIH HHS,0.854,no,no,no,0.563,0.843,0.668,no,GO:0006952,0.526
RSCID.457170.77522,GSE21477,Gene Expression Changes in Primary Human Nasal Epithelial Cells exposed to Formaldehyde in vitro,39,treatment,1x,4x,536,NA,0.885,yes,no,no,NA,NA,0.907,no,GO:0009888,0.557
RSCID.456981.40041,GSE21497,"Common Gene Transcriptional Patterns Following Immobilization, Spinal Cord Injury, and Unloading in Human Skeletal Muscle",20,timepoint,2 days,5 days,4,NICHD NIH HHS,0.768,no,no,no,0.634,0.598,0.487,no,GO:0099512,0.862
RSCID.457423.70737,GSE21510,Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer,148,disease,Colorectal Cancer,reference subject role,501,NA,0.846,yes,no,no,NA,NA,0.825,no,GO:0022402,0.529
RSCID.459925.112489,GSE21545,Biobank of Karolinska Endarterectomy (BiKE),223,cell type,Plaque,mononuclear cell,1698,NA,0.857,no,no,no,NA,NA,0.86,no,GO:0040011,0.538
RSCID.448990.77528,GSE21610,Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support,38,disease staging,Heart failure,reference subject role,55,NA,0.784,no,no,no,NA,NA,0.627,no,GO:0006955,0.567
RSCID.460510.70016,GSE21723,Expression profiling of vascular endothelial cells using minimal input material,64,sex,female,male,26,NA,0.658,no,no,no,NA,NA,0.592,no,GO:0048471,0.562
RSCID.457128.67686,GSE21858,Patterns of gene expression and evolution in the human developing cerebral cortex,8,timepoint,17 gestational weeks,19 gestational weeks,24,NIGMS NIH HHS,0.804,no,no,no,0.637,0.764,0.724,no,GO:0010638,0.562
RSCID.449691.64878,GSE21912,The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells,21,treatment,reference substance role,doxycycline; reference substance role,1,NA,0.336,no,no,no,NA,NA,NA,no,NA,NA
RSCID.461530.76038,GSE21935,Comparison of post-mortem tissue from Brodman Brain BA22 region between schizophrenic and control patients,42,sex,female,male,5,NA,1,no,yes,no,NA,NA,1,no,GO:0060765,0.624
RSCID.440650.70713,GSE21942,Expression data from peripheral blood mononuclear cells in multiple sclerosis patients and controls,29,disease,Multiple Sclerosis,reference subject role,39,NA,0.895,yes,no,yes,NA,NA,NA,no,GO:0006928,0.554
RSCID.465235.122009,GSE21979,Transcriptional and post-transcriptional regulation of VEGF by the unfolded protein response,4,timepoint,8 h,initial time point,408,NCI NIH HHS,0.584,yes,no,no,0.555,0.571,0.506,no,GO:0007186,0.529
RSCID.459926.101717,GSE22038,Gene expression following epigenetic drug treatment,14,treatment,z-aza-DC + TSA,reference substance role,126,NA,0.836,no,no,no,NA,NA,NA,no,GO:0009888,0.538
RSCID.459398.76975,GSE22138,Expression Data from Uveal Melanoma primary tumors.,63,sex,male,female,4,NA,1,no,yes,no,NA,NA,1,no,GO:0060765,0.666
RSCID.439639.70627,GSE22224,Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients under Cyclosporin A or Sirolimus Monotherapy,32,treatment,sirolimus inhibitor,reference subject role,28,NA,0.886,no,no,yes,NA,NA,0.5,no,GO:0043168,0.585
RSCID.439633.70261,GSE22377,mRNA expression data from human adenocarcinomas of the stomach,43,disease,intestinal adenocarcinoma of the stomach,diffuse adenocarcinoma of the stomach,227,NA,0.885,yes,no,no,NA,NA,NA,no,GO:0031012,0.554
RSCID.449049.40210,GSE22513,Markers of Taxane Sensitivity in Breast Cancer,28,phenotype,pathological complete response: no,pathological complete response: yes,90,NA,0.826,no,no,no,NA,NA,0.604,no,GO:0060548,0.547
RSCID.455515.75287,GSE22541,Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals,68,disease,pulmonary metastasis of clear-cell renal cell carcinoma,primary clear-cell renal cell carcinoma,8450,NA,0.524,no,no,no,NA,NA,NA,no,GO:0070727,0.524
RSCID.439635.70342,GSE22563,Identification of TSGs Frequently Methylated in Renal Cell carcinoma (expression profiles of Renal cell lines following  de-methylation),22,treatment,5-Aza-2'-deoxycytidine,reference subject role,161,NA,0.769,no,no,no,NA,NA,0.55,no,GO:0022414,0.544
RSCID.466665.123667,GSE22707,Absence of significant overlap in transcriptional patterns between operationally  tolerant liver and kidney recipients,48,treatment,transplantation; kidney,reference subject role,3,NA,0.919,no,no,no,NA,NA,NA,no,GO:0045429,0.999
RSCID.439622.70493,GSE22845,"Gene expression profiling of CEBPA double-, single-mutant and CEBPA wild type AML",149,genetic modification,CEBPA wild-type; acute myeloid leukemia,CEBPA double-mutant; acute myeloid leukemia,182,NA,0.84,no,no,no,NA,NA,0.573,no,GO:0051240,0.543
RSCID.457875.86413,GSE22875,OTX2 drives medulloblastoma proliferation via direct regulation of cell cycle genes and inhibits differentiation,24,treatment,shRNA; silenced_gene; OTX2 [human] orthodenticle homeobox 2,reference substance role,26,NA,0.876,no,no,no,NA,NA,0.544,no,GO:0044432,0.562
RSCID.456999.40114,GSE23073,Transcriptome profiling of genes regulated by RXR and its partners in monocyte-derived dendritic cells,12,individual,donor 1,donor 2,12,NA,0.893,no,no,no,NA,NA,NA,no,GO:0009986,0.623
RSCID.449947.75841,GSE23120,Basal gene expression data from Human Variation Panel,191,population,Han Chinese-American,African-American,3,NIGMS NIH HHS,0.929,no,no,no,0.592,0.902,0.659,no,GO:0005501,0.749
RSCID.460053.100668,GSE23194,Mucosal biopsies from groups Normal (NOR) and patients who underwent curative large bowel resection for colorectal cancer  (M-CRC),17,clinical history,curative large bowel resection for CRC,reference subject role,4,NA,0.826,no,no,no,NA,NA,0.622,no,GO:0016229,0.749
RSCID.439575.69433,GSE23293,Definition and characterization of the systemic T cell dysregulation in untreated indolent B cell lymphoma and very early CLL,24,disease,follicular/extranodal marginal zone lymphomas,reference subject role,11,NA,0.867,no,no,no,NA,NA,0.64,no,GO:0006935,0.705
RSCID.459389.69087,GSE23376,Gene expression data from stage IV melanoma patients,14,sex,male,unknown sex,16,NA,0.542,no,no,no,NA,NA,0.505,no,GO:1902533,0.586
RSCID.459932.111439,GSE23394,Expression data from human NHL cell lines treated with agonistic antibodies,48,cell line,REC-1,SU-DHL4,991,NA,0.777,no,no,no,NA,NA,0.811,no,GO:0006955,0.525
RSCID.459411.70512,GSE23501,DNA methylation signatures define molecular subtypes of Diffuse Large B Cell Lymphoma,69,sex,male,female,6,NCI NIH HHS,1,no,yes,no,0.999,0.999,1,no,GO:0060765,0.599
RSCID.466845.124114,GSE23553,Gene expression changes with induction of in-vitro platinum-resistance in ovarian cancer cell lines.,16,treatment,3 x 3 ug/mL; cisplatin,reference substance role,29,NCI NIH HHS,0.696,no,no,no,0.616,0.7,0.55,no,GO:0031967,0.589
RSCID.440032.69413,GSE23583,Highly efficient reprogramming to pluripotency and directed differentiation using synthetic mRNA,22,cell type,fibroblast,RNA; pluripotent stem cell,2100,NA,0.79,yes,no,no,NA,NA,0.833,no,GO:0007049,0.526
RSCID.434792.76987,GSE23593,Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome,50,clinical history,progesterone receptor status: PR(-),progesterone receptor status: PR(+),15,NCI NIH HHS,0.833,no,no,no,0.836,0.84,0.6,no,GO:0048699,0.611
RSCID.441046.75871,GSE23604,ECP mediated monocyte to DC differentiation,23,timepoint,post-ECP,pre-ECP,503,NCI NIH HHS,0.824,yes,no,no,0.787,0.812,NA,no,GO:0006955,0.55
RSCID.448900.40182,GSE23687,Expression data from SPARKS CHARMS JIA cohort,22,treatment,methotrexate,reference substance role,14,NA,0.849,no,no,no,NA,NA,0.686,no,GO:0005694,0.634
RSCID.442153.69057,GSE23806,"Expression data of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors",59,cell line,glioblastoma stem-like cell line,Glioma,1084,NA,0.814,yes,no,no,NA,NA,0.836,no,GO:0045595,0.538
RSCID.456988.40091,GSE23878,Genome Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy,59,disease,Colorectal Cancer,reference subject role,185,NA,0.927,yes,no,no,NA,NA,0.928,no,GO:0009719,0.553
RSCID.446746.82767,GSE2397,LJMJDW: Cellular responses to 4-hydroxy-2-nonenal,24,timepoint,24 h,6 h,38,NCI NIH HHS,0.568,no,no,no,0.563,0.599,0.542,no,GO:0030029,0.551
RSCID.434856.69010,GSE23994,A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers,24,cell type,stromal cell,epithelial cell,2536,NCI NIH HHS,0.776,no,no,no,0.764,0.765,0.835,no,GO:0009888,0.528
RSCID.427433.70622,GSE24223,Deconvoluting Early Post-Transplant Immunity Using Purified Cell Subsets Reveals Functional Networks Not Evident by Whole Blood Analysis,102,cell type,CD14,blood,1030,NIAID NIH HHS,0.692,yes,no,no,0.627,0.679,0.663,no,GO:0002684,0.523
RSCID.434829.70364,GSE24235,Skeletal muscle gene expression in response to resistance exercise: sex specific regulation,28,sex,female,male,7,NINDS NIH HHS,0.997,no,yes,no,0.911,0.993,0.9,no,GO:0060765,0.599
RSCID.448814.38919,GSE24265,Expression data from human brain samples,11,sex,male,female,5,NA,0.998,no,yes,no,NA,NA,1,no,GO:0016577,0.749
RSCID.439511.70390,GSE24337,The Human Airway Epithelial Basal Cell Transcriptome,23,cell type,undifferentiated cell; inflammatory cell; ciliated cell; epithelial cell; secretory cell; basal cell,basal cell,3458,NHLBI NIH HHS,0.696,no,no,no,0.562,0.693,0.715,no,GO:0006928,0.525
RSCID.434712.70433,GSE24362,Epstein Barr virus Nuclear Antigen 3C regulated genes in Lymphoblastoid Cell Lines,22,cell line,LCL C19,LCL C15,55,NA,0.885,no,no,no,NA,NA,0.568,no,GO:0009986,0.575
RSCID.439516.68981,GSE24422,Effect of insulin on the stromal and adipocyte cells within hMSC derived adipocytes,24,treatment,Insulin,reference subject role,9,NA,0.929,no,no,no,NA,NA,0.729,no,GO:0042981,0.694
RSCID.440876.75323,GSE24468,Elucidation of the Mechanisms by which the Progesterone Receptor Inhibits Inflammatory Responses in Cellular Models of Breast Cancer,20,treatment,PR agonist R5020,reference subject role,159,NICHD NIH HHS,0.873,yes,no,no,0.689,0.869,0.876,no,GO:0043067,0.564
RSCID.458053.83485,GSE24547,Transcriptional pathway signatures for the Aurora inhibitor Danusertib,20,treatment,Danusertib; 24 hours; 1 uM,Untreated; reference subject role,1,NA,0.906,no,no,no,NA,NA,0.987,no,GO:0070265,0.999
RSCID.459560.70333,GSE24739,Gene expression differences between highly enriched normal and chronic myelogenous leukemia quiescent stem/progenitor cells and correlations with biological abnormalities,24,timepoint,G1 phase of cell cycle,G0 phase of cell cycle,51,NA,0.899,no,no,no,NA,NA,0.481,no,GO:0006955,0.595
RSCID.439503.70766,GSE24795,Gene Expression differences between replication error deficient and proficient colorectal cancers: the dominant role of deletions in 3â€™UTR poly T sequences,30,cell line,replication error deficient,replication error proficient,13,NA,0.815,no,no,no,NA,NA,0.579,no,GO:0071248,0.613
RSCID.457133.74173,GSE24810,Dissecting the signalling pathways underlying cellular senescence,9,treatment,"38Â°C, 7 days",38Â°C for 7 days + back to 33.5Â°C,47,NA,0.929,no,no,no,NA,NA,0.54,no,GO:0022402,0.605
RSCID.441820.70305,GSE24849,Human CD34+-derived erythoblast (polychromatophilic and orthochromatic) response to co-culture with Plasmodium falciparum 3D7,28,treatment,Infection; Plasmodium falciparum,no infection; reference subject role,22,NHLBI NIH HHS,0.648,no,no,no,0.657,0.667,NA,no,GO:0009725,0.582
RSCID.458033.83634,GSE25014,Gene expression data of endothelium exposed to heme,24,treatment,vehicle,ferric heme; 5 uM,554,NIAID NIH HHS,0.854,no,no,no,0.673,0.838,0.877,no,GO:0051240,0.534
RSCID.457525.73412,GSE25119,Comparison of CD4+ T cells from human fetal and adult donors,21,developmental stage,Adult,Fetal structure,104,NA,0.895,yes,no,no,NA,NA,0.62,no,GO:0006955,0.572
RSCID.457512.73502,GSE25155,Tribbles 3 - a novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide,24,cell line,MKN45,HEK-TLR2,1235,NA,0.801,no,no,no,NA,NA,0.824,no,GO:0030054,0.529
RSCID.446662.83543,GSE25487,"Expression of SV40 TAg signature in MDAMB231 cells, tumors, and normal human mammary epithelial cells (M98040 and M99005)",6,cell line,MDAMB231; breast cancer,healthy; CK0082; normal,2072,NA,0.76,no,no,no,NA,NA,0.801,no,GO:0009888,0.521
RSCID.427334.70263,GSE25550,t(11;18)-positive vs. t(11;18)-negative MALT lymphoma,13,disease,t(11;18)-negative,reference subject role,1341,NICHD NIH HHS,0.833,no,no,no,0.594,0.805,0.828,no,GO:0040011,0.527
RSCID.441886.70822,GSE25613,A Novel Pro-Survival Function of Cyclin-D1 Underlies Its Oncogenic Role and Potential as a Therapeutic Target in Human and Murine Mantle Cell Lymphoma,4,cell line,JEKO,G519,1025,NCI NIH HHS,0.777,no,no,no,0.739,0.754,0.776,no,GO:0050776,0.527
RSCID.453233.99111,GSE25746,"Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma",12,cell line,HPAF1,HPAM1,265,NA,0.761,no,no,no,NA,NA,0.831,no,GO:0007267,0.525
RSCID.459549.70142,GSE26104,Search for specific biomarkers of IFN-beta bioactivity in patients with MS,12,timepoint,betaferon; 12 months,baseline participant role,4,NA,0.968,no,no,no,NA,NA,0.75,no,GO:0006952,0.855
RSCID.457400.69955,GSE26339,Expression data from pericardial and subcutaneous adipose tissue and adipocytes,50,organism part,fat cell; adipose tissue; pericardium,fat cell; subcutaneous adipose tissue,12,NHLBI NIH HHS,0.917,no,no,no,0.585,0.886,0.535,no,GO:0006366,0.664
RSCID.439458.70116,GSE26378,Expression data from validation cohort of children with septic shock,103,disease,Septic shock,reference subject role,116,NIGMS NIH HHS,0.915,no,no,yes,0.991,0.943,0.985,yes,GO:0006955,0.579
RSCID.439459.71498,GSE26440,Expression data for derivation of septic shock subgroups,113,disease,septic shock outcome: Survivor,reference subject role,117,NIGMS NIH HHS,0.925,no,no,no,0.984,0.954,0.986,yes,GO:0006955,0.582
RSCID.436349.70039,GSE26459,High-throughput ectopic expression screen for tamoxifen resistance,24,strain,MCF7-G11TamR,MCF7-B7TamS,218,NA,0.799,no,no,no,NA,NA,0.732,no,GO:0045595,0.539
RSCID.459548.69230,GSE26511,Involvement of the TGF-? and ?-catenin pathways in pelvic lymph node metastasis in early stage cervical cancer,39,disease,Cervix carcinoma; metastatic; lymph node,Cervix carcinoma; reference subject role; lymph node,3,NA,0.896,no,no,no,NA,NA,0.496,no,GO:0008285,0.821
RSCID.434599.70316,GSE26599,Gene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2 overexpressing human mammary epithelial cell lines,40,cell line,C5.2,HB4a,580,NA,0.829,no,no,no,NA,NA,0.881,no,GO:0009888,0.533
RSCID.458931.83561,GSE26637,Adipose tissue transcriptome in insulin resistance,20,phenotype,Obesity; Insulin resistance,lean; increased insulin sensitivity; baseline participant role,54,NA,0.934,no,no,no,NA,NA,0.571,no,GO:0006955,0.584
RSCID.459906.102731,GSE26656,Gene expression profiles of Wnt-1 overexpressing melanoma,24,cell line,M24met melanoma cell-line,A375,906,NA,0.801,no,no,no,NA,NA,0.817,no,GO:0040011,0.519
RSCID.427492.70846,GSE26713,Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T-ALL,124,disease,pediatric T-ALL,reference subject role,464,NA,0.864,yes,no,no,NA,NA,NA,no,GO:0006952,0.594
RSCID.459898.102735,GSE26748,Gene expression profiling of cidofovir treatment and resistance in SiHa cells,24,phenotype,resistant to,susceptible toward,219,NA,0.839,yes,no,no,NA,NA,0.684,no,GO:0051270,0.539
RSCID.457025.64918,GSE2677,Prednisolone treated childhood ALL samples,39,disease,precursor B lymphoblastic lymphoma/leukemia,precursor T-lymphoblastic lymphoma/leukemia,715,NA,0.795,no,no,no,NA,NA,0.841,no,GO:0002684,0.547
RSCID.461475.83602,GSE26886,"Gene expression profiling of Barrett's esophagus, adenocarcinoma, esophageal squamous epithelium and squamous cell carcinoma",40,disease,esophagus adenocarcinoma,reference subject role,1030,NA,0.832,yes,no,no,NA,NA,0.835,no,GO:0009888,0.536
RSCID.439489.71511,GSE26906,APC colon stage II,84,organism part,metastasis: LIVER,metastasis: no,1,NA,1,no,no,no,NA,NA,1,no,GO:0035924,0.999
RSCID.434691.69915,GSE26910,Stromal molecular signatures of breast and prostate cancer,24,disease,tumorous,reference subject role,28,NA,0.945,no,no,no,NA,NA,0.735,no,GO:0031012,0.598
RSCID.439499.69909,GSE26966,Identification of Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors,23,disease,Gonadotrope tumor,Hypophysis,1041,NA,0.814,no,no,no,NA,NA,0.809,no,GO:0045595,0.534
RSCID.463750.118397,GSE27041,OXPHOS complex I deficiency leads to transcriptional changes of the Nrf2-Keap1 pathway and selenoproteins.,20,growth condition,Glucose,galactose,1,NA,0.967,no,no,no,NA,NA,0.997,no,GO:0030216,0.999
RSCID.446599.83101,GSE2706,TLR agonists on human dendritic cells,12,timepoint,8 h,0 h,1126,NIAID NIH HHS,0.723,yes,no,no,0.736,0.723,0.699,no,GO:0006952,0.542
RSCID.466700.123761,GSE27120,Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment,50,treatment,co-cultured; MDA-MB-361; breast adenocarcinoma,reference subject role,47,NA,0.942,no,no,no,NA,NA,NA,no,GO:0030198,0.582
RSCID.443086.90242,GSE27206,"Global gene expression profiles of iPSC from SMA patient, unaffected father and iPS 19.9 compared to transcriptomic data obtained by corresponding fibroblasts",9,cell type,fibroblast,iPSC,1405,NA,0.813,yes,no,no,NA,NA,0.856,no,GO:0009888,0.527
RSCID.459401.96422,GSE27262,Gene expression profiling of Non-small cell lung cancer in Taiwan,50,disease,Adenocarcinoma,reference subject role,421,NA,0.9,no,no,no,NA,NA,0.962,no,GO:0040011,0.544
RSCID.448955.39292,GSE2748,A molecular classification of papillary renal cell carcinoma,34,phenotype,molecular class type 1,molecular class type 2,95,NA,0.69,no,no,no,NA,NA,NA,no,GO:0055086,0.533
RSCID.459962.99932,GSE27536,Vastus lateralis biopsies from healthy and COPD patients before and after 8 weeks of exercise training,54,treatment,exercise,reference subject role,4,NA,0.987,no,no,no,NA,NA,0.833,no,GO:0030199,0.874
RSCID.428019.73429,GSE27562,Expression data from human PBMCs from breast cancer patients and controls,162,treatment,validation data set,training data set,5,NCI NIH HHS,0.865,no,no,no,0.624,0.629,0.746,no,GO:0098687,0.693
RSCID.439487.68973,GSE27651,The Anterior Gradient Homolog 3 (AGR3) Gene Is Associated with Differentiation and Survival in Ovarian Cancer,28,disease staging,high-grade; ovarian carcinoma; serous,surface epithelium; ovary,652,NCI NIH HHS,0.825,no,no,no,0.812,0.807,0.833,no,GO:0007049,0.544
RSCID.459130.90463,GSE27657,Human subcutaneous adipose tissue and perithyroid adipose tissue gene expression,18,sex,female,male,5,NA,1,no,yes,no,NA,NA,1,no,GO:0060765,0.624
RSCID.434657.69897,GSE27838,Gene expression of expanded and non-expanded natural killer cells from healthy donor and myeloma patients,32,cell type,Non-expanded; natural killer cell,Expanded; natural killer cell,1554,NCRR NIH HHS,0.746,no,no,no,0.549,0.733,0.735,no,GO:0007049,0.547
RSCID.436799.70373,GSE27887,Reversal of Atopic Dermatitis with Narrow-Band UVB Phototherapy and Biomarkers for Therapeutic Response,35,timepoint,After,Before,4,NCRR NIH HHS,0.853,no,no,no,0.692,0.844,NA,no,GO:0045087,0.865
RSCID.459397.75960,GSE27914,"Expression data from LNCap cell line treated with COP1 (RFWD2), ETV1, and JUN siRNAs",14,treatment,control siRNA,COP1 (RFWD2) siRNA,3,NA,0.621,no,no,no,NA,NA,0.488,no,GO:0032436,0.665
RSCID.459157.90495,GSE27916,"Human subcutaneous adipose tissue gene expression (SOS Sib-pair study, offspring cohort)",375,sex,female,male,7,NA,0.934,no,yes,no,NA,NA,0.9,no,GO:0010880,0.583
RSCID.458257.90870,GSE27928,Characterization of gene expression of tumor infiltrating T cells (TILs) in previously untreated patients with follicular lymphoma (FL) compared with those of tonsils,35,organism part,tonsil,lymph node,21,NCI NIH HHS,0.907,no,no,no,0.819,0.86,0.558,no,GO:0006955,0.647
RSCID.458023.83659,GSE28005,Charaterization of the initial molecular events of adipose tissue development and growth during overfeeding in humans,38,phenotype,overweight,lean; reference subject role,100,NA,0.826,no,no,no,NA,NA,0.598,no,GO:0031012,0.558
RSCID.442221.69648,GSE28044,Expression data from non-malignant fallopian tube epithelium,24,timepoint,follicular epithelial cell,luteal cell,4,NA,0.581,no,no,no,NA,NA,0.748,no,GO:0042493,0.746
RSCID.457483.73375,GSE28050,Expression data from knockdown of BACH1 in HEK 293T cells,25,timepoint,72 hrs,24 hrs,1,NA,0.981,no,no,no,NA,NA,1,no,GO:0009649,0.999
RSCID.458479.79397,GSE28133,Transcriptomic analysis of human retinal detachment (RD) reveals both inflammation and photoreceptor death,38,disease,retinal detachment,reference subject role,276,NA,0.825,no,no,no,NA,NA,0.662,no,GO:0006952,0.593
RSCID.458935.83591,GSE28160,Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-Associated Neurocognitive Disorders,23,disease,Untreated; HIV-1 associated neurocognitive disorder,reference subject role,196,NINDS NIH HHS,0.866,no,no,no,0.749,0.851,0.867,no,GO:0007267,0.574
RSCID.461771.118181,GSE28238,Low grade gliomas,40,organism part,supratentorial,infratentorial,93,NA,0.771,no,no,no,NA,NA,0.5,no,GO:0097458,0.549
RSCID.458485.79281,GSE28392,Effects of resistance exercise on the transcriptome in MHC I and MHC IIa muscle fibers of young and old women,70,age,young,old,3,NA,0.77,no,no,no,NA,NA,0.663,no,GO:0043679,0.666
RSCID.455887.79293,GSE28422,Effects of resistance exercise and resistance training on the skeletal muscle transcriptome in young and old adults,110,sex,female,male,15,NA,0.9,no,no,no,NA,NA,0.937,no,GO:0016577,0.599
RSCID.436796.69555,GSE28548,The effect of sirtuin 6 overexpression on TNFa stimulation.,24,treatment,TNF [human] tumor necrosis factor,reference subject role,32,NA,0.934,yes,no,no,NA,NA,NA,no,GO:0002684,0.73
RSCID.459242.94925,GSE28619,"Transcriptome Analysis Identifies Fn14, a TNF Superfamily Receptor Member, as a Therapeutic Target in Alcoholic Hepatitis",22,disease,alcoholic hepatitis,reference subject role,227,NA,0.885,yes,no,no,NA,NA,0.875,no,GO:0040011,0.543
RSCID.436821.69257,GSE28726,"NKT, CD1d-aGC+ Va24-, and CD4 T cell clones from human peripheral blood",28,timepoint,18 days,3 days,3654,NIAID NIH HHS,0.607,yes,no,no,0.58,0.607,0.526,no,GO:0015630,0.512
RSCID.458148.83867,GSE28750,Development and Validation of a Novel Molecular Biomarker Diagnostic Test for the Early Detection of Sepsis,31,disease,Post-surgical,healthy; reference subject role,66,NA,0.879,no,no,no,NA,NA,0.869,no,GO:0006955,0.58
RSCID.439685.69402,GSE28796,Gene expression profiles of pretreatment biopsies from dose-dense-docetaxel-treated breast cancers,24,disease,pathological complete response: no,pathological complete response: yes,714,NCI NIH HHS,0.7,no,no,no,0.683,0.691,0.597,no,GO:0048878,0.517
RSCID.459400.67560,GSE28914,Human Skin Transcriptome during Epidermal Wound Healing,14,disease,3rd post-operative day sample,intact skin sample,740,NA,0.859,yes,no,no,NA,NA,0.695,no,GO:0006952,0.575
RSCID.439687.69400,GSE28996,Xenograft model systems of adenoid cystic carcinoma,22,cell type,adenoid cystic carcinoma; xenograft,adenoid cystic carcinoma,146,NA,0.904,no,no,no,NA,NA,0.505,no,GO:0050776,0.574
RSCID.459120.83532,GSE29008,Human colon epithelial treated with Clostridium difficile Toxins A and B,14,timepoint,6 hours,24 hours,5,NIAID NIH HHS,0.858,no,no,no,0.842,0.749,0.7,no,GO:0000982,0.693
RSCID.436809.69196,GSE29137,Numb variant specific transcriptome analysis,24,strain,MB231,MCF7,3525,NA,0.69,yes,no,no,NA,NA,0.741,no,GO:0051270,0.517
RSCID.460000.116799,GSE29265,Sporadic vs. Post-Chernobyl Papillary vs. Anaplastic Thyroid Cancers,40,disease staging,papillary thyroid carcinoma,reference subject role,149,NA,0.868,no,no,no,NA,NA,0.565,no,GO:0007155,0.543
RSCID.459125.83841,GSE29326,Gene expression profiling of pediatric myelodysplastic syndrome (MDS) characterizes disease subtype and time to progression into acute myeloid leukemia (AML),19,disease,excess of blast; Refractory anemia,refractory cytopenia,18,NA,0.938,no,no,no,NA,NA,NA,no,GO:0048646,0.606
RSCID.459575.70634,GSE29368,CD140a+ human glial progenitor cells,10,genotype,CD140a-,CD140a+,393,NINDS NIH HHS,0.824,yes,no,no,0.726,0.807,0.688,no,GO:0022008,0.542
RSCID.466707.123779,GSE29431,Identifying breast cancer biomarkers,66,organism part,breast,Breast Carcinoma,521,NA,0.854,no,no,no,NA,NA,0.898,no,GO:0009719,0.537
RSCID.439696.69267,GSE29450,Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers,20,disease,ovarian carcinoma; Clear cell,reference subject role,2062,NA,0.732,no,no,no,NA,NA,0.763,no,GO:0009888,0.521
RSCID.457440.68746,GSE29544,Expression profiling of human T-LL cell line CUTLL1,45,molecular entity,cycloheximide,reference substance role,15,NCI NIH HHS,0.91,no,no,no,0.86,0.887,0.633,no,GO:0000981,0.619
RSCID.436830.68628,GSE29605,Gene expression data from chronic lymphocytic leukemia samples,22,treatment,mutated IgVH,reference subject role,8,NA,0.926,no,no,no,NA,NA,0.497,no,GO:1901136,0.638
RSCID.459577.73143,GSE29614,Time Course of Young Adults Vaccinated with Influenza TIV Vaccine during 2007/08 Flu Season,18,timepoint,post-vaccination; 7 days,pre-vaccination; 0 days,6,NIAID NIH HHS,0.968,no,no,no,0.618,0.869,0.75,no,GO:0051249,0.893
RSCID.458120.84954,GSE29628,The time-course transcriptomic responses of THP-1 human macrophage-like cells  to W-Beijing Mycobacterium tuberculosis strains of different sublineages,14,timepoint,4 hours,reference subject role,30,NA,0.906,no,no,no,NA,NA,0.553,no,GO:0032101,0.623
RSCID.450988.83806,GSE29672,The transcription factors Snail and Slug activate the TGF-B signaling pathway in breast cancer,12,timepoint,Day 1,Day 0,415,NA,0.75,no,no,no,NA,NA,0.725,no,GO:0007049,0.634
RSCID.457490.73520,GSE29683,Coexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis [human tumor/cell line data],58,cell type,Primary Tumor,xenograft-passaged,260,NA,0.832,no,no,no,NA,NA,0.845,no,GO:0042981,0.539
RSCID.459579.73126,GSE29721,The landscape of promoter DNA hypomethylation in liver cancer (expression data),20,disease,hepatocellular carcinoma,reference subject role,237,NA,0.84,no,no,no,NA,NA,0.631,no,GO:0043436,0.567
RSCID.459811.112534,GSE29796,Transcriptional Differences between Normal and Glioma-Derived Glial Progenitor Cells Identify a Core Set of Dysregulated Genes.,42,organism part,A2B5pos; Tumor,A2B5pos; white matter,1107,NINDS NIH HHS,0.726,yes,no,no,0.606,0.709,0.596,no,GO:0006952,0.527
RSCID.458521.77239,GSE29807,Gene expression study reveals compromised Pattern Recognition Receptors and Interferon Signaling in fullterm Low birth Weight newborns,12,phenotype,Low birth weight,reference subject role,1,NA,0.912,no,no,no,NA,NA,0.496,no,GO:0002833,0.999
RSCID.436870.68631,GSE29828,Expression Profiling of Mixed Lineage Leukemia Cells Treated with a Potent Small-Molecule DOT1L Inhibitor,24,treatment,3 uM; EPZ004777,reference subject role,30,NHLBI NIH HHS,0.717,no,no,no,0.597,0.71,0.544,no,GO:0043436,0.586
RSCID.439710.68616,GSE29881,Human endothelial gene expression under estradiol and oxLDL treatments,10,treatment,Oxidized; estradiol; Low density lipoprotein,reference subject role,14,NA,0.95,no,no,no,NA,NA,0.915,no,GO:0060337,0.845
RSCID.455002.69779,GSE29903,Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids,72,treatment,1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine,oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine,20,NHLBI NIH HHS,0.846,yes,no,no,0.727,0.798,0.644,no,GO:0032269,0.636
RSCID.459799.108905,GSE29986,gene expression analyses of pediatric  lymphoblastic lymphomas and leukemias,26,disease,T-cell lymphoblastic lymphoma,common lymphoblastic leukemia,833,NA,0.83,no,no,no,NA,NA,0.787,no,GO:0006955,0.543
RSCID.451538.93255,GSE30188,Rho transcription inhibitor CCG-1423 effect on PC-3 cells,20,timepoint,24 hours,2 hours,56,NIDDK NIH HHS,0.903,no,no,no,0.678,0.889,NA,no,GO:0022402,0.759
RSCID.453098.98591,GSE30219,"\Off-context\"" gene expression in lung cancer identifies a group of metastatic-prone tumors""",99,disease,Adenocarcinoma of Lung,reference subject role,232,NCI NIH HHS,0.9,no,no,no,0.846,0.848,0.926,no,GO:0006928,0.541
RSCID.439661.69586,GSE30391,Expression data from human Wharton's jelly stem cells,6,timepoint,passage 8,passage 1,698,NA,0.756,no,no,no,NA,NA,0.614,no,GO:0007049,0.571
RSCID.459213.88421,GSE30439,Exposure of cystic fibrosis bronchial epithelial cells (CFBE 41 o-) to Pseudomonas aeruginosa (PA01) biofilms,16,treatment,Pseudomonas aeruginosa,reference substance role,34,NHLBI NIH HHS,0.966,yes,no,no,0.73,0.952,0.77,no,GO:0002684,0.671
RSCID.439659.68586,GSE30499,Inhibition of nonsense-mediated RNA decay by the tumor microenvironment promotes tumorigenesis,10,timepoint,4.5 hr,0 hr,183,NIDDK NIH HHS,0.64,no,no,no,0.506,0.616,0.536,no,GO:0042981,0.561
RSCID.459816.108105,GSE30516,Dynamic re-wiring of apoptotic signaling networks enhances tumor cell killing by DNA damage,19,cell line,BT20,MCF-7,1905,NA,0.754,no,no,no,NA,NA,0.791,no,GO:0048699,0.517
RSCID.465295.121210,GSE30599,EZH2 mutations can be detected in 23% of PICALM-MLLT10 (CALM-AF10) positive acute leukemias,29,genotype,Homozygous negative; EZH2 [human] enhancer of zeste 2 polycomb repressive complex 2 subunit,wild type genotype,6,NA,0.781,no,no,no,NA,NA,NA,no,GO:0004674,0.656
RSCID.457509.72881,GSE30674,"Profiling of Jurkat T cells activated with CD3, CD28 and PMA and multiple kinase inhibitors",26,medical procedure,"AEB,701",dimethyl sulfoxide; reference subject role,98,NA,0.857,no,no,no,NA,NA,0.692,no,GO:0006955,0.639
RSCID.459069.84919,GSE30718,Molecular Phenotypes of Acute Kidney Injury in Kidney Transplants,39,treatment,acute kidney injury,pristine protocol biopsy,1,NA,0.991,no,no,no,NA,NA,1,no,GO:0090504,0.999
RSCID.459812.102839,GSE30723,Gene Expression Profiles of human primary alveolar type II (ATII) cells and macrophages (AMs) after influenza virus infection,24,timepoint,24 hours,4 hours,4,NHLBI NIH HHS,0.917,no,no,no,0.677,0.925,0.623,no,GO:0044255,0.852
RSCID.463838.119234,GSE30985,Expression profiling of DNMT1 inhibitors in HCT116 cells,6,treatment,Prodrug G669043; 1500nM; prodrug role,reference substance role,27,NA,0.804,no,no,no,NA,NA,0.786,no,GO:0005925,0.57
RSCID.458889.87484,GSE30999,Expression data from skin biopsy samples from patients with moderate-to-severe psoriasis,170,disease,lesion; Psoriasis,reference subject role,146,NA,0.896,yes,no,no,NA,NA,0.927,no,GO:0006955,0.611
RSCID.459311.98073,GSE31048,Expression data from normal B cells and chronic lymphocytic leukemia B cells -- with/without treatment of Wnt3a,221,treatment,Wnt3a peptide,reference subject role,49,NCI NIH HHS,0.888,yes,no,no,0.807,0.871,NA,no,GO:0042981,0.613
RSCID.459251.95376,GSE31192,Molecular Signature of Pregnancy Associated Breast Cancer (PABC),33,clinical history,pregnancy,reference subject role,3,NCI NIH HHS,0.894,no,no,no,0.805,0.826,0.747,no,GO:0017134,0.749
RSCID.459494.99357,GSE31210,Gene expression data for pathological stage I-II lung adenocarcinomas,147,genotype,EGFR [human] epidermal growth factor receptor,wild type genotype,192,NA,0.893,no,no,no,NA,NA,0.965,no,GO:0040011,0.559
RSCID.463839.118627,GSE31311,High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas,22,genotype,Overexpression; MYC [human] v-myc avian myelocytomatosis viral oncogene homolog,wild type genotype,1,NA,0.966,no,no,no,NA,NA,1,no,GO:0001658,0.999
RSCID.466876.124217,GSE31448,"Down-regulation of ECRG4, a candidate tumor suppressor gene  in human breast cancer",357,organism part,breast,Breast Carcinoma,370,NA,0.891,no,no,no,NA,NA,0.92,no,GO:0022402,0.549
RSCID.459262.97736,GSE31455,Primary human hepatocytes treated with IL28B and the HCV JFH1 Genotype 2A clone.,9,treatment,"hepatitis C infection, JFH1 clone",reference subject role,382,NA,0.785,no,no,no,NA,NA,0.716,no,GO:0006955,0.575
RSCID.461494.75462,GSE3151,Oncogene Signature Dataset,20,genotype,Overexpression; MYC [human] v-myc avian myelocytomatosis viral oncogene homolog,wild type genotype,14,NCI NIH HHS,0.734,no,no,no,0.757,0.742,0.545,no,GO:0043565,0.622
RSCID.459039.84765,GSE31684,Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer Â ,47,disease staging,pT3,pTa,32,NCI NIH HHS,0.926,no,no,no,0.911,0.896,0.571,no,GO:0051270,0.627
RSCID.459716.108377,GSE31782,Knock-down and Over-expression of JMJD6 in MCF-7 and/or MDA-MB231,28,cell line,MCF-7,MDAMB231,1713,NA,0.808,yes,no,no,NA,NA,0.854,no,GO:0051270,0.526
RSCID.459712.102216,GSE32100,Glioma cells oxygen response,22,cell line,primary glioblastoma culture,U87,1413,NA,0.811,yes,no,no,NA,NA,0.848,no,GO:0051240,0.523
RSCID.457936.85559,GSE32323,"Screening for Epigenetically Masked Genes in Colorectal Cancer using 5-aza-2â€™-deoxycytidine treatment, Microarray and Gene Expression Profile",27,disease,noncancerous,CRC cell line,2099,NA,0.747,no,no,no,NA,NA,0.733,no,GO:0022402,0.519
RSCID.459714.101738,GSE32374,Clinical and Molecular Characteristics of  Congenital Glioblastoma Multiforme,18,age,pediatric,adult,1,NCI NIH HHS,0.501,no,no,no,0.553,0.652,NA,no,GO:0003743,0.999
RSCID.458819.85131,GSE32474,Comparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0),41,disease,Melanoma,breast cancer,550,NCI NIH HHS,0.857,no,no,no,0.844,0.837,0.884,no,GO:0051270,0.546
RSCID.459457.39859,GSE3292,Gene expression signature of HPV in head and neck squamous cell carcinoma,36,phenotype,HPV negative,HPV positive,33,NA,0.84,no,no,no,NA,NA,0.558,no,GO:0008236,0.579
RSCID.457910.84408,GSE32924,Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities,21,disease,atopic dermatitis; skin lesions,reference subject role,42,NCRR NIH HHS,0.85,no,no,no,0.98,0.874,0.555,no,GO:0009888,0.589
RSCID.460276.89724,GSE32959,An integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiation,16,timepoint,12 h,72 h,537,NA,0.728,yes,no,no,NA,NA,0.639,no,GO:0007049,0.587
RSCID.458803.84402,GSE32962,In vitro prednisolone resistance signature in MLL-rearranged infant ALL,43,phenotype,prednisolone; sensitive toward,prednisolone; resistant to,9,NA,0.878,no,no,no,NA,NA,NA,no,GO:0006366,0.649
RSCID.466885.124262,GSE32975,Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma,54,treatment,gefitinib,reference substance role,19,NCI NIH HHS,0.894,yes,no,no,0.869,0.862,0.667,no,GO:0040011,0.645
RSCID.441117.88073,GSE33006,Gene expression profiles from the hepatocellular carcinoma (HCC) tissues,6,disease,hepatocellular carcinoma,adjacent normal tissue; reference substance role; liver,21,NA,0.704,no,no,no,NA,NA,0.538,no,GO:0034097,0.642
RSCID.459678.104052,GSE33135,Gene expression profile after dexamethasone in chronic lymphocytic leukemia cells according to IGHV/ZAP-70 status,24,genotype,mutated IGHV + Low ZAP-70 expression,wildtype IGHV + High ZAP-70 expression,43,NA,0.859,no,no,no,NA,NA,0.568,no,GO:0051050,0.543
RSCID.458395.95044,GSE33223,Multilineage dysplasia does not influence prognosis in patients with CEBPA mutated AML supporting the WHO proposal to classify these patients as a unique entity,21,disease,acute myeloid leukemia,reference subject role,22,NA,0.851,no,no,no,NA,NA,0.873,no,GO:0030054,0.612
RSCID.460262.89670,GSE33630,Normal thyrocytes vs papillary vs anaplastic thyroid carcinomas,94,disease,Papillary thyroid carcinoma,thyroid; reference subject role; normal,210,NA,0.876,yes,no,no,NA,NA,NA,no,GO:0007155,0.548
RSCID.459648.102319,GSE33903,Expression array of peripheral neuro-ectodermal cell lines,22,organism part,Neuroblastoma,reference subject role,291,NA,0.825,no,no,no,NA,NA,0.711,no,GO:0022008,0.544
RSCID.454609.108564,GSE33939,Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human polymorphonuclear leukocyte gene expression and enhance bactericidal capacity.,21,treatment,Panton-Valentine leukocidin,reference subject role,189,NCRR NIH HHS,0.721,no,no,no,0.601,0.726,NA,no,GO:0040011,0.543
RSCID.458901.86785,GSE33950,SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors,8,treatment,Sharp1 overexpression,shGFP; reference substance role,46,NA,0.894,no,no,no,NA,NA,0.531,no,GO:0005789,0.55
RSCID.461661.117836,GSE34156,Human monocyte activation with NOD2L vs. TLR2/1L,45,treatment,muramyl dipeptide,reference substance role,16,NIAID NIH HHS,0.966,yes,no,no,0.943,0.95,0.59,no,GO:0071345,0.843
RSCID.459156.90612,GSE34248,Gene expression profiling in psoriatic lesional and non-lesional skin [Set 1],28,organism part,lesional skin,non-lesional skin,85,NA,0.916,yes,no,no,NA,NA,0.97,no,GO:0006955,0.641
RSCID.459263.94747,GSE34308,Gene expression profiles of fibroblasts from childhood cerebral adrenoleukodystrophy patients and healthy controls,10,disease,adrenoleukodystrophy,reference subject role,59,NIGMS NIH HHS,0.905,no,no,no,0.683,0.869,0.546,no,GO:0031012,0.568
RSCID.460248.89555,GSE34526,Differential Gene Expression in Granulosa Cells from Polycystic Ovary Syndrome Patients with and without Insulin Resistance:  Identification of Susceptibility Gene Sets through Network Analysis,10,disease,Polycystic Ovary Syndrome,reference subject role,3,NICHD NIH HHS,0.963,no,no,no,0.779,0.924,NA,no,GO:0071326,0.666
RSCID.459629.110901,GSE34733,"Methylation of the Proximal, Distal and Core Promoter of CEBPA in 572 Cases with Normal Karyotpye AML and 44 with t(8;21) Disclosed Different Frequencies but no Impact on Prognosis",18,genotype,CEBPA non-methylated/non-mutated,CEBPA single-mutated,6,NA,0.916,no,no,no,NA,NA,0.916,no,GO:0051186,0.659
RSCID.459631.100292,GSE34824,Frequent driver mutations in histone H3.3 and chromatin remodeling genes in paediatric glioblastoma,23,genotype,H3F3A status: K27M,H3F3A status: wild type; wild type genotype,1,NA,0.629,no,no,no,NA,NA,0.98,no,GO:0042571,0.5
RSCID.459641.100299,GSE35144,Molecular Evaluation of Patient-Derived Colorectal Cancer Explants as a Pre-clinical Mouse Model of Colorectal Cancer,64,organism part,human tumor,PDCCE tumor,338,NA,0.933,yes,no,no,NA,NA,0.939,no,GO:0031012,0.574
RSCID.459647.110980,GSE35230,"Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour",38,cell line,A375,16R6-4,163,NA,0.878,yes,no,no,NA,NA,0.795,no,GO:0009888,0.549
RSCID.459288.95652,GSE35283,Highly pathogenic influenza virus inhibit Inflammatory Responses in Monocytes via Activation of the Rar-Related Orphan Receptor Alpha (RORalpa),6,treatment,PR8-infected,reference subject role; uninfected,83,NA,0.8,no,no,no,NA,NA,0.57,no,GO:0006955,0.652
RSCID.459591.108397,GSE35331,Expression data from Bone-Marrow Mesenchymal Stromal Cells (BM-MSC) from Follicular Lymphoma patient (FL) or Healthy Donor (HD).,22,disease,follicular lymphoma,reference subject role,1,NA,0.924,no,no,no,NA,NA,NA,no,NA,NA
RSCID.459608.112216,GSE35428,Transcriptional profiling of clinically relevant SERMs and SERM/estradiol complexes in a cellular model of breast cancer,106,treatment,E2,reference substance role,51,NIDDK NIH HHS,0.887,no,no,no,0.667,0.872,NA,no,GO:0022402,0.628
RSCID.461474.90822,GSE35493,Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes,30,disease,large cell medulloblastoma,reference subject role,1057,NCI NIH HHS,0.79,no,no,no,0.747,0.762,0.783,no,GO:0097458,0.538
RSCID.462189.119191,GSE35683,Exogenous Interleukin-10 versus Glucocorticoids: Effect on Gene Expression and Pro-inflammatory Cytokine Release in Polymorphonuclear Leukocytes and Monocytes of the Newborn,30,cell type,monocyte,granulocyte,890,NICHD NIH HHS,0.731,yes,no,no,0.546,0.737,0.724,no,GO:0006955,0.543
RSCID.460414.116463,GSE35713,Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes,132,treatment,recent onset; diabetes mellitus type 1,control,1,NIDDK NIH HHS,0.89,no,no,no,0.46,0.931,0.566,no,GO:0008146,0.999
RSCID.459247.95387,GSE36000,Mantle Cell Lymphoma,38,genetic modification,IGHV@ [human] immunoglobulin heavy variable cluster,wild type genotype,39,Intramural NIH HHS,0.872,no,no,no,0.603,0.835,0.596,no,GO:0022008,0.571
RSCID.455300.112573,GSE36059,Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies; Molecular diagnosis of antibody-mediated rejection in human kidney transplants,289,phenotype,non-rejecting,reference subject role,15,NA,0.984,no,no,no,NA,NA,0.642,no,GO:0045944,0.728
RSCID.463609.121264,GSE36076,A combined strategy of global gene expression analysis and multiplex PCR established a 13-member gene signature for the diagnosis of human hepatocellular carcinoma.,20,disease staging,hepatocellular carcinoma,reference subject role,21,NA,0.973,yes,no,no,NA,NA,1,no,GO:0042981,0.622
RSCID.459557.104730,GSE36287,"Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)",9,treatment,interferon gamma,reference subject role,306,NA,0.861,yes,no,no,NA,NA,0.635,no,GO:0006955,0.592
RSCID.461408.75442,GSE3629,Molecular Marker for predicting development of cancer in ulcerative colitis,121,disease,Colorectal Cancer,ulcerative colitis,13268,NA,0.59,yes,no,no,NA,NA,NA,no,GO:0030054,0.514
RSCID.460311.101414,GSE36547,Assessment of Ex Vivo Prostaglandin pathway activation in HSCs,20,treatment,prostaglandin E2,reference substance role,14,NIDDK NIH HHS,0.901,no,no,no,0.571,0.848,0.624,no,GO:0071495,0.658
RSCID.459033.98435,GSE36640,Lamin B1 Depletion in Senescent Cells Triggers Large-Scale Changes in Gene Expression and in the Chromatin Landscape [ expression array ],10,phenotype,senescent,proliferative,624,NA,0.806,no,no,no,NA,NA,0.657,no,GO:0007049,0.583
RSCID.460308.108120,GSE36700,Gene expression profiles in synovial biopsies from patients with arthritis,12,disease,Rheumatoid Arthritis,osteoarthritis,96,NA,0.888,no,no,no,NA,NA,0.609,no,GO:0006955,0.646
RSCID.459260.94785,GSE36766,Effect of human breast tumor supernatant on normal CD4+ T cells (Confirmation Set SN),14,treatment,carcinoma; cell culture supernatant,reference subject role,23,NA,0.89,no,no,no,NA,NA,0.583,no,GO:0009968,0.66
RSCID.461942.118621,GSE36782,Glioma-propagating cells as an in vitro screening platform: PLK1 as a case study,22,disease,anaplastic oligoastrocytoma,glioblastoma multiforme,24,NA,0.638,no,no,no,NA,NA,0.545,no,GO:0008284,0.55
RSCID.467000.124632,GSE36809,A genomic storm in critically injured humans,211,timepoint,12 h,initial time point,395,NIGMS NIH HHS,0.824,no,no,no,0.871,0.846,0.857,yes,GO:0006955,0.553
RSCID.455439.104766,GSE36830,Gene expression analysis of Chronic rhinosinusitis,24,organism part,nasal polyp (NP) tissue,uncinate tissue (UT),303,NIAID NIH HHS,0.733,no,no,no,0.646,0.741,0.589,no,GO:0006928,0.535
RSCID.461535.88527,GSE36842,Progressive Activation of Th2/Th22 characterizes acute and chronic atopic dermatitis,23,disease,Non-lesional; atopic dermatitis,reference subject role,727,NCRR NIH HHS,0.733,no,no,no,0.629,0.715,0.556,no,GO:0009888,0.534
RSCID.460291.100385,GSE36895,Molecular Genetic Classification of clear-cell Renal Cell Carcinoma (ccRCC) based on the Gene Expression Profiling of Tumors and Tumorgrafts deficient for BAP1 or PBRM1,55,genotype,BAP1 wild type/PBRM1 wild type,BAP1 loss/PBRM1 wild type,16,NCI NIH HHS,0.78,no,no,no,0.791,0.758,0.541,no,GO:0008285,0.565
RSCID.460368.112442,GSE36911,Gene expression levels in immortalized B cells from 131 unrelated CEPH-Utah grandparents treated under ER stress.,262,treatment,tunicamycin,reference substance role,25,NIDDK NIH HHS,0.842,no,no,no,0.621,0.816,0.499,no,GO:0034976,0.646
RSCID.458265.92072,GSE37069,Gene response to major burn injuries,590,clinical history,Burn injury,reference subject role,164,NIGMS NIH HHS,0.888,no,no,yes,0.969,0.916,0.973,yes,GO:0050776,0.574
RSCID.455275.112180,GSE37171,Expression data from uremic patients and 20 healthy controls (normals),115,disease,Renal failure,reference subject role,19,NA,0.677,no,no,no,NA,NA,0.526,no,GO:0032269,0.583
RSCID.433408.80529,GSE37290,Expression Data from HNF1b-knockdown RMG2-ovarian cancer cells,20,genotype,knock down; HNF1b; shRNA,reference subject role,291,NA,0.855,yes,no,no,NA,NA,0.887,no,GO:0040012,0.54
RSCID.461426.90492,GSE37364,Expression data from human colonic biopsy samples  (adenoma-carcinoma),67,disease,Adenoma,reference subject role,167,NA,0.877,yes,no,no,NA,NA,0.968,no,GO:0006820,0.549
RSCID.448940.39301,GSE3744,Human breast tumor expression,27,disease,non-basal-like cancer,reference subject role,668,NCI NIH HHS,0.882,no,no,no,0.862,0.86,0.846,no,GO:0009888,0.537
RSCID.460247.112252,GSE37567,Methodoligies for identifying lead toxicity,102,treatment,lead acetate,reference substance role,5,NA,0.967,no,no,no,NA,NA,0.749,no,GO:0010043,0.799
RSCID.458600.80576,GSE37645,The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models,18,phenotype,MRK003; non-sensitive; resistant to,MRK003; sensitive toward,109,NCI NIH HHS,0.902,no,no,no,0.885,0.877,0.596,no,GO:0009888,0.556
RSCID.453580.100960,GSE37648,Gene signatures of normal hTERT immortalized ovarian epithelium and fallopian tube epithelium (paired cultures from 2 donor patients),12,organism part,fallopian tube,female gonad,7,NCI NIH HHS,0.869,no,no,no,0.868,0.867,0.662,no,GO:0046006,0.571
RSCID.467022.124725,GSE37745,"Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis and tissue microarray validation",196,sex,male,female,16,NA,0.948,no,no,no,NA,NA,0.675,no,GO:0030139,0.694
RSCID.459199.91099,GSE37838,Comparing three phenotypes: Comparing molecular assessment of implantation biopsy,78,cell type,Kidney transplant biopsy,nephrectomy; reference subject role,26,NA,0.897,no,no,no,NA,NA,0.693,no,GO:0042981,0.606
RSCID.457887.86141,GSE38010,Janus-Like Opposing Roles of CD47 in Autoimmune Brain Inflammation in Human and Mice,4,disease,Healthy control,Chronic active plaque,647,NIAID NIH HHS,0.74,no,no,no,0.576,0.727,0.731,no,GO:0097458,0.544
RSCID.463787.118373,GSE38517,"Expression data from fibroblasts derived from human normal oral mucosa, oral dysplasia and oral squamous cell carcinoma",20,growth condition,Monolayer culture,3D culture,218,NA,0.876,no,no,no,NA,NA,0.884,no,GO:0031012,0.553
RSCID.460261.111566,GSE38663,Effect of Ribavirin on Viral Kinetics and Liver Gene Expression in Chronic Hepatitis C,29,treatment,pegylated-interferon,reference substance role,19,NA,0.936,no,no,no,NA,NA,NA,no,GO:0043207,0.804
RSCID.461663.117844,GSE38666,Molecular Profiling provides evidence of the existence of two functionally distinct classes of ovarian cancer stroma,45,cell type,surface epithelium of ovary,ovary stroma,349,NA,0.886,no,no,no,NA,NA,0.903,no,GO:0007155,0.534
RSCID.458233.91515,GSE38718,Sex and aging effect on skeletal muscle transcriptome in humans,22,phenotype,female,male,5,NINDS NIH HHS,0.999,no,yes,no,1,0.998,1,no,GO:0060765,0.666
RSCID.457968.87020,GSE38836,T Cell Activation in Microgravity Compared to 1g (Earth's) Gravity,6,treatment,activated; normal gravity (1g),microgravity; activated,2,NA,0.989,no,no,no,NA,NA,NA,no,GO:0006611,0.749
RSCID.459237.95073,GSE38941,Liver Regeneration Gene Signature in Hepatitis B virus (HBV)-Associated Acute Liver Failure Identified by Gene Expression Profiling,27,disease,"Liver Failure, acute",reference subject role,1056,NCI NIH HHS,0.825,yes,no,no,0.76,0.779,0.822,no,GO:0043436,0.547
RSCID.460680.117472,GSE39091,Expression data of A375 melanoma cells after DMSO or MLN4924 +/- Nutlin treatment for 26 hours,30,treatment,MLN4924,reference substance role,222,NA,0.787,no,no,no,NA,NA,0.714,no,GO:0009888,0.533
RSCID.460147.108839,GSE39133,Gene expression profiling of microdissected HRS cells,34,cell type,Hodgkin Reed-Sternberg cell,germinal center,1024,NA,0.73,no,no,no,NA,NA,0.755,no,GO:0006955,0.52
RSCID.458712.93265,GSE39156,A transcriptionally induced antioxidant program is elicited in thyroid cells after exposure to hydrogen peroxide,64,organism part,thyrocyte,T cell,3016,NA,0.775,yes,no,no,NA,NA,0.784,no,GO:0006928,0.523
RSCID.454319.107741,GSE39293,"Gene expression profiling of cidofovir treatment and resistance inHeLa, HaCaT, and PHK cells",18,treatment,cidofovir dihydrate,reference subject role,4,NA,0.947,no,no,no,NA,NA,0.744,no,GO:0061178,0.666
RSCID.460143.108725,GSE39409,Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome,16,disease,ampulla of Vater adenocarcinoma,extrahepatic bile duct carcinoma,48,NCI NIH HHS,0.853,no,no,no,0.816,0.837,NA,no,GO:0044092,0.6
RSCID.460230.89426,GSE39454,Expression data from myositis muscles,15,disease,inclusion body myositis,reference subject role,370,NA,0.888,no,no,no,NA,NA,0.819,no,GO:0006955,0.619
RSCID.460144.112089,GSE39612,Distinct gene expression profiles of viral- and non-viral associated Merkel cell carcinoma revealed by transcriptome analysis,102,disease,primary merkel cell carcinoma,reference subject role,1410,NCI NIH HHS,0.813,no,no,no,0.795,0.804,0.805,no,GO:0009888,0.53
RSCID.440733.87843,GSE39843,Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress,12,treatment,"2,3-dimethoxy-1,4-naphthoquinone; oxidative stress",reference substance role,14,NA,0.863,no,no,no,NA,NA,0.497,no,GO:0006979,0.725
RSCID.453801.101473,GSE3998,Prostate cell specific expression,10,cell type,endothelial cell,basal cell of prostate epithelium,492,NIDDK NIH HHS,0.853,no,no,no,0.565,0.854,0.853,no,GO:0006955,0.529
RSCID.458286.88436,GSE40160,Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma,9,cell type,classical Hodgkin lymphoma (cHL) cell line sample,B-cell lymphoma,1400,NA,0.621,no,no,no,NA,NA,0.578,no,GO:0070647,0.52
RSCID.460166.112406,GSE40231,The Stockholm Atherosclerosis Gene Expression (STAGE) study: Global Gene Expression data from coronary and carotid artery disease patients,106,organism part,muscle,Atherosclerosis; aorta,2129,NA,0.732,yes,no,no,NA,NA,0.728,no,GO:0003012,0.524
RSCID.461722.117970,GSE40413,IL-17 and TNF synergistically induce growth-associated cytokines in melanocytes while suppressing melanogenesis,12,timepoint,24 h,48 h,7,NA,0.817,no,no,no,NA,NA,0.582,no,GO:0005261,0.635
RSCID.458266.91045,GSE40438,Gene expression profiling of resistant and vulnerable motor neuron subtypes in amyotrophic lateral sclerosis,8,organism part,oculomotor neurons,lumbar spinal; motor neuron,3,NA,0.972,no,no,no,NA,NA,0.662,no,GO:0030183,0.665
RSCID.461626.88292,GSE40611,Gene expression data of parotid tissue from Primary Sjogrenâ€™s Syndrome and controls,49,disease,Sjogren's syndrome,reference subject role,248,NA,0.835,no,no,no,NA,NA,0.809,no,GO:0006955,0.584
RSCID.458287.88445,GSE40613,Effects of co-culture of  Endothelial Cells with Mesenchymal Stem Cells on Gene Expression,8,cell type,Mesenchymal stem cell; Co-Cultured,Mesenchymal stem cell,196,NHLBI NIH HHS,0.875,no,no,no,0.676,0.856,0.894,no,GO:0072359,0.568
RSCID.458991.98301,GSE40791,Usp44 binds centrin to regulate centrosome positioning and suppress tumorigenesis,169,disease,stage I; lung adenocarcinoma,reference subject role,364,NA,0.909,no,no,no,NA,NA,0.974,no,GO:0040011,0.535
RSCID.441200.88410,GSE40885,Data expression in alveolar macrophages induced by lipopolysaccharide in humans,14,treatment,lipopolysaccharide,saline; reference substance role,133,NA,0.906,yes,no,no,NA,NA,0.919,no,GO:0006955,0.634
RSCID.458276.88450,GSE40968,The effect of ACSL4 expression on overall gene expression in breast cancer cell lines,18,cell line,MCF7,SKBR3,1361,NCI NIH HHS,0.754,no,no,no,0.737,0.738,0.78,no,GO:0009888,0.517
RSCID.459118.98664,GSE41040,Gene expresion changes following knockdown of KDM4C in primary fibroblasts,14,genetic modification,KDM4C [human] lysine (K)-specific demethylase 4C,wild type genotype,98,NIDDK NIH HHS,0.884,yes,no,no,0.596,0.856,0.733,no,GO:0007049,0.559
RSCID.459333.39452,GSE4107,Expression profiling in early onset colorectal cancer,22,disease,early onset colorectal cancer,reference subject role,108,NA,0.929,no,no,no,NA,NA,NA,no,GO:0030054,0.562
RSCID.447287.90454,GSE41168,Resveratrol supplementation does not improve metabolic function in non-obese women with normal glucose tolerance,140,organism part,adipose tissue,skeletal muscle tissue,2408,NA,0.725,no,no,no,NA,NA,0.717,no,GO:0030054,0.524
RSCID.459136.98791,GSE41177,Region-specific gene expression profiles in left atria of patients with valvular atrial fibrillation,38,organism part,junction; left cardiac atrium,left atrium auricular region,19,NA,0.872,no,no,no,NA,NA,0.56,no,GO:0007155,0.635
RSCID.459229.88696,GSE41315,Timecourse gene expression profiling of DLBCL cell line Karpas422 after EZH2 inhibitor treatment,24,treatment,EZH2 inhibitor; 5 uM,dimethyl sulfoxide; reference subject role,298,NA,0.831,no,no,no,NA,NA,0.567,no,GO:0006952,0.557
RSCID.459221.88674,GSE41328,Colorectal adenocaricinomas and matched normal colonic tissues,20,disease,Colorectal Cancer,reference subject role,281,NCI NIH HHS,0.889,yes,no,no,0.796,0.818,0.924,no,GO:0030198,0.541
RSCID.459152.90610,GSE41662,Gene expression profiling in psoriatic lesional and non-lesional skin [Set 2],48,disease,lesional skin,non-lesional skin,145,NA,0.889,yes,no,no,NA,NA,0.974,no,GO:0006955,0.573
RSCID.454978.75346,GSE4183,"Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature",23,disease,Adenoma,reference subject role,340,NA,0.822,yes,no,no,NA,NA,0.819,no,GO:0040011,0.54
RSCID.460254.89628,GSE42088,Expression data from Leishmania major infected human dendritic cells,15,treatment,Leishmania major species complex,reference subject role; uninfected,1,NIGMS NIH HHS,1,no,no,no,0.864,0.998,1,no,GO:0035924,0.999
RSCID.458179.90641,GSE42114,Creation of differentiation-specific genomic maps of human epidermis through laser capture microdissection,13,organism part,Suprabasal; skin epidermis,reference subject role; skin epidermis,314,NIGMS NIH HHS,0.705,no,no,no,0.626,0.7,NA,no,GO:0022402,0.548
RSCID.466748.123870,GSE42392,Expression analysis of cancer of unknown primary (CUP),60,organism part,lymph node,pleural fluid; peritoneal fluid,321,NA,0.905,yes,no,no,NA,NA,0.906,no,GO:0030198,0.568
RSCID.455048.110994,GSE4246,Analysis of transcripts regulated by Dicer and Argonaute proteins in human HEK-293 cells,16,genotype,Dicer kd,wild type genotype,77,NA,0.684,no,no,no,NA,NA,0.498,no,GO:0006396,0.543
RSCID.453514.100541,GSE42549,Transcriptional responses of mantle cell lymphoma (MCL) lines to PKC inhibition,16,treatment,AEB071,reference subject role,20,NA,0.703,no,no,no,NA,NA,NA,no,GO:0030054,0.607
RSCID.458475.94055,GSE42568,Breast Cancer Gene Expression Analysis,121,disease,breast cancer,reference subject role,514,NA,0.866,no,no,no,NA,NA,0.878,no,GO:0009888,0.538
RSCID.460074.102403,GSE42660,BL2 cells stimulated with B cell specific paracrine stimuli,6,treatment,rhBAFF,reference subject role,1,NA,0.981,no,no,no,NA,NA,0.999,no,GO:0043542,0.999
RSCID.464932.121902,GSE42762,FOXO3a Is A Major Target Of Inactivation By PI3K/AKT Signaling In Aggressive Neuroblastoma,12,treatment,PI-103,reference substance role,336,NA,0.553,no,no,no,NA,NA,NA,no,GO:0042175,0.52
RSCID.457892.86036,GSE4290,Expression data of glioma samples from Henry Ford Hospital,104,disease,Glioblastoma,non-tumor; Epilepsy; reference subject role,459,NA,0.824,no,no,no,NA,NA,0.937,no,GO:0097458,0.56
RSCID.459146.90686,GSE42952,Molecular markers associated with outcome and metastasis in human pancreatic cancer,13,disease,liver metastasis,Poor outcome; Pancreatic Ductal Adenocarcinoma,581,NA,0.789,no,no,no,NA,NA,0.824,no,GO:0006082,0.571
RSCID.461727.117991,GSE43010,HDAC Inhibitors induce tumor cell-selective pro-apoptotic transcriptional responses.,42,cell line,LTSTERas; BJ cell,BJ cell,468,NA,0.884,yes,no,no,NA,NA,0.92,no,GO:0031012,0.558
RSCID.461770.118179,GSE43289,Gene expression profiles of gliomas with Affymetrix Human Genome U133 Plus 2.0 Array,40,sex,female,male,7,NA,0.999,no,yes,no,NA,NA,1,no,GO:0051704,0.647
RSCID.465220.122000,GSE43552,Expression profiling of human medulloblastoma cell line ONS76 upon siRNA-mediated knockdown of KDM5A/LSD1,6,genotype,Knockdown; KDM5A [human] lysine (K)-specific demethylase 5A,wild type genotype,19,NA,0.903,no,no,no,NA,NA,0.562,no,GO:0034097,0.719
RSCID.463746.119049,GSE43596,Global gene expression analysis in macrophages treated with Nutlin-3,18,treatment,lipopolysaccharide,reference substance role,335,Intramural NIH HHS,0.802,yes,no,no,0.754,0.798,0.838,no,GO:0006955,0.587
RSCID.455596.100490,GSE4386,Transcriptomics in cardiac surgery,40,treatment,sevoflurane,propofol,102,NA,0.836,no,no,no,NA,NA,0.568,no,GO:0044432,0.552
RSCID.459190.96959,GSE44126,Expression data from Human CD40L+ Tcells,10,cell type,CD8+/CD40L+,CD4+/CD40L+,58,NIAID NIH HHS,0.871,yes,no,no,0.743,0.873,0.652,no,GO:0006955,0.656
RSCID.451181.91017,GSE44541,Expression data from antimycin A-treated BE(2)-C cells,6,treatment,purified; antimycin A,reference subject role,154,NIAID NIH HHS,0.619,no,no,no,0.523,0.609,0.506,no,GO:0043168,0.55
RSCID.458898.99459,GSE44765,Global profiling of human hair follicle scalp dermal papilla cells using Affymetrix microarrays,6,cell type,passage 0,scalp,1666,NIGMS NIH HHS,0.795,no,no,no,0.609,0.781,0.795,no,GO:0009888,0.525
RSCID.458673.93336,GSE44809,Primary human bronchial epithelial cells expressing EGFP or DN-GRHL2,9,genetic modification,Green fluorescent protein,GRHL2 [human] grainyhead-like 2 (Drosophila),6,NHLBI NIH HHS,0.89,no,no,no,0.82,0.832,0.621,no,GO:0008092,0.65
RSCID.444841.17293,GSE4483,Astrocyte and Hela cell response to hypoxia,12,cell type,Astrocyte,HeLa,2975,NINDS NIH HHS,0.714,no,no,no,0.535,0.704,0.737,no,GO:0045595,0.522
RSCID.461058.94745,GSE45516,Expression data from human Huntington fibroblasts,9,disease,Huntington Disease,reference subject role,67,NA,0.71,no,no,no,NA,NA,0.507,no,GO:0051345,0.536
RSCID.458476.94077,GSE45899,Expression profiling of glioblastoma cancer stem cells,6,cell type,MGG8,neuronal stem cell,752,NA,0.807,no,no,no,NA,NA,0.827,no,GO:0009888,0.529
RSCID.456141.16289,GSE4600,Identifying targets of MeCP2 during neuronal maturational differentiation,12,developmental stage,undifferentiated SH-SY5Y cells,differentiated SH-SY5Y cells,49,NINDS NIH HHS,0.829,no,no,no,0.623,0.812,0.552,no,GO:0034976,0.579
RSCID.460036.111025,GSE46170,Whole Genome Expression Array in Human T-cell Acute Lymphoblastic Leukemia,33,organism part,T-cell acute lymphoblastic leukemias; bone marrow,"CD3,CD4,CD8poz; thymus",63,NA,0.831,no,no,yes,NA,NA,NA,no,GO:0001775,0.564
RSCID.460043.111107,GSE46480,Peripheral blood mononuclear cell (PBMC) gene expression in healthy adults rapidly transported to high altitude,196,environmental stress,base camp,high altitude,23,NA,0.615,no,no,no,NA,NA,0.548,no,GO:0031966,0.617
RSCID.458426.95572,GSE46493,Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells (Affymetrix),6,treatment,Nutlin-3,reference subject role,92,NA,0.836,no,no,no,NA,NA,0.569,no,GO:0048468,0.548
RSCID.459448.96562,GSE46914,IDENTIFICATION OF BIOMARKERS OF RESPONSE TO IFNG DURING ENDOTOXIN TOLERANCE: APPLICATION TO SEPTIC SHOCK,12,treatment,twice; lipopolysaccharide; interferon gamma,reference subject role,65,NA,0.894,no,no,no,NA,NA,0.582,no,GO:0006952,0.661
RSCID.459195.96955,GSE46922,Differences in gene expression and cytokines levels between newly diagnosed and chronic pediatric immune thrombocytopenia (ITP),13,disease,chronic,newly diagnosed,2,NA,0.781,no,no,no,NA,NA,0.487,no,GO:0032897,0.749
RSCID.458527.93884,GSE47130,Vector-transduced neurons transcriptome profiles,30,timepoint,2 hours,5 hours,1,NA,0.995,no,no,no,NA,NA,1,no,GO:0006984,0.999
RSCID.443655.16131,GSE4773,Greene-5P01NS017771-220003,15,timepoint,1 weeks,4 weeks,65,NA,0.629,yes,no,no,NA,NA,0.509,no,GO:1901700,0.559
RSCID.458458.95564,GSE47855,"Gene expression analysis for CD56- T, NK, CD56+ T cells, and iNKT cells",10,cell type,CD56- T Cell,CD56+ T Cell,305,NCI NIH HHS,0.76,no,no,no,0.718,0.76,0.727,no,GO:0051240,0.533
RSCID.459987.101532,GSE48046,Gene expression analysis of Early immature  and Late mature T-ALL cell lines,4,cell line,RPMI8402,DND41,619,NCI NIH HHS,0.812,no,no,no,0.794,0.804,0.798,no,GO:0050776,0.522
RSCID.459258.95314,GSE48258,Changes in gene expression induced by CDK9 inhibition alone and in combination with fludarabine,6,treatment,cyclin-dependent kinase inhibitors,reference subject role,11,NA,0.914,no,no,no,NA,NA,0.497,no,GO:0006955,0.63
RSCID.463906.121350,GSE48498,Transcripts expression of Infliximab therapy for patients with Kawasaki disease,28,phenotype,Immunoglobulin G; resistant to,reference subject role,8,NA,0.855,no,no,no,NA,NA,0.624,no,GO:0006959,0.664
RSCID.459364.95862,GSE48611,Gene expression of human isogenic trisomy 21 induced pluripotent stem cells and derived neurons,18,cell type,induced pluripotent stem cell,Neuron,1611,NICHD NIH HHS,0.772,no,no,no,0.572,0.745,0.783,no,GO:0022008,0.528
RSCID.459220.96901,GSE49515,Expression profiling of PBMC from patients with hepatocellular carcinoma,20,disease,hepatocellular carcinoma,reference subject role,21,NA,0.973,yes,no,no,NA,NA,1,no,GO:0042981,0.622
RSCID.459101.74841,GSE4984,Monocyte Derived Dendritic Cell Maturation,6,treatment,vehicle; reference substance role,untreated; reference substance role,1,NIAID NIH HHS,0.865,no,no,no,0.894,0.781,0.488,no,GO:0042571,0.5
RSCID.461709.117955,GSE49910,An Expression Atlas of Human Primary Cells: Inference of Gene Function from Coexpression Networks,11,cell type,"effector memory CD8-positive, alpha-beta T cell",CD4-positive helper T cell,652,NA,0.717,no,no,no,NA,NA,0.559,no,GO:0006955,0.54
RSCID.464192.121528,GSE49938,Re-specification of myeloid precursors from human pluripotent cells into engraftable multi-lineage progenitors,26,genotype,Overexpression; RORA [human] RAR-related orphan receptor A,wild type genotype,470,NIDDK NIH HHS,0.822,no,no,no,0.558,0.811,0.683,no,GO:0006955,0.556
RSCID.453177.98993,GSE49953,Expression data from two breast cancer cell lines,16,cell line,T47D,MDAMB231,1635,NCI NIH HHS,0.783,no,no,no,0.778,0.773,0.823,no,GO:0009888,0.522
RSCID.454619.108627,GSE49954,T lymphocytes from Chronic HCV-infected patients express unique pro-apoptotic gene signature.,30,cell type,CD8+ T-cells,CD4+ T cell,395,NA,0.867,yes,no,no,NA,NA,0.897,no,GO:0006955,0.59
RSCID.458950.98100,GSE49958,"Gene expression in human umbilical cord vein and artery endothelial cells under physiological chronic normoxia (3% O2, PCN) and standard culture normoxia (21% O2, SCN)",23,organism part,umbilical vein,umbilical artery,70,NHLBI NIH HHS,0.884,no,no,no,0.727,0.864,0.723,no,GO:0045595,0.559
RSCID.458820.99119,GSE50058,A common rejection module for acute rejection in multiple organs identifies novel therapeutics.,101,disease,Transplanted Organ Complication,reference subject role,11,NCI NIH HHS,0.97,no,no,no,0.928,0.941,0.666,no,GO:0006955,0.83
RSCID.459991.112115,GSE50161,Expression data from human brain tumors and human normal brain,47,disease,ependymoma,Temporal lobe,907,NCI NIH HHS,0.697,no,no,no,0.665,0.677,0.768,no,GO:0042995,0.553
RSCID.449438.76168,GSE5040,Polyamides alleviate transcription inhibition associated with long GAAâ€¢TTC repeats in Friedreichâ€™s ataxia,24,disease,Friedreich Ataxia,reference subject role,2,NA,0.948,no,no,no,NA,NA,NA,no,GO:0005865,0.749
RSCID.459014.98330,GSE50568,Expression data from N/Tert-HPV E6 cells in the presence and absence of mitomycin C treatment,34,treatment,mitomycin C,reference subject role,39,NCI NIH HHS,0.872,no,no,no,0.853,0.833,0.691,no,GO:0044092,0.552
RSCID.459995.101854,GSE50572,Gene signature of CLL cells cultured with activated T cells or CD40L-expressing cells,12,treatment,CD40L fibroblasts,reference substance role,674,NA,0.733,no,no,no,NA,NA,0.617,no,GO:0006955,0.529
RSCID.460475.64865,GSE5086,Transcriptional profile of aging human muscle,81,organism part,rectus abdominis,reference subject role,4,NA,0.806,no,no,no,NA,NA,0.662,no,GO:0072329,0.748
RSCID.459153.98887,GSE50948,Expression Data from transNOAH breast cancer trial,156,genotype,"ERBB2 [human] v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)",wild type genotype,5,NA,0.789,no,no,no,NA,NA,0.665,no,GO:2000145,0.784
RSCID.448579.35149,GSE5105,gene expression profiles in T-lymphocytes and Monocytes of participants of the Tour de France 2005,66,cell type,monocyte,T cell,16369,NA,0.491,yes,no,no,NA,NA,0.502,no,GO:0009719,0.512
RSCID.464831.121778,GSE51395,"ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis",20,genotype,"Knockdown; ST3GAL1 [human] ST3 beta-galactoside alpha-2,3-sialyltransferase 1",wild type genotype,41,NA,0.711,no,no,no,NA,NA,0.548,no,GO:0007010,0.573
RSCID.458862.99449,GSE51401,Expression data from tumor-associated endothelial cells of hepatocellular carcinoma,64,disease,cancer,reference subject role,456,NA,0.871,no,no,no,NA,NA,0.871,no,GO:0030162,0.533
RSCID.458915.99624,GSE51725,EGFR expression status associated with lymph node ratio,6,disease,stomach cancer; low,reference subject role,2,NA,0.531,no,no,no,NA,NA,0.745,no,GO:0001540,0.749
RSCID.455959.101102,GSE51812,Identification of chondrocyte subsets during human development,12,cell type,chondrocyte; cell condensation,limb cell,63,NA,0.883,no,no,no,NA,NA,0.577,no,GO:0048468,0.568
RSCID.464941.121914,GSE51978,Gene expression profiling in neuroblastoma cells upon CHAF1A silencing,9,genotype,"Knockdown; CHAF1A [human] chromatin assembly factor 1, subunit A (p150)",wild type genotype,7,NA,0.692,no,no,no,NA,NA,0.625,no,GO:0008207,0.599
RSCID.463835.118949,GSE51997,T helper lymphocyte- and monocyte-specific type I interferon (IFN) signatures in autoimmunity and viral infection.,25,disease staging,systemic lupus erythematosus,reference subject role,78,NA,0.92,no,no,no,NA,NA,NA,no,GO:0006955,0.634
RSCID.459974.99834,GSE52037,Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expression,20,disease,ovarian cancer,reference subject role,497,NA,0.86,no,no,no,NA,NA,0.883,no,GO:0009888,0.529
RSCID.455960.101074,GSE52081,Contribution of paracrine signalling on dendritic cell activation,6,treatment,Newcastle disease,reference subject role,1013,NIAID NIH HHS,0.777,no,no,no,0.764,0.769,0.747,no,GO:0006952,0.554
RSCID.453416.99863,GSE52158,Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells,6,cell type,AFBLy-based differentiation,posterior foregut endoderm,965,NHLBI NIH HHS,0.816,no,no,no,0.609,0.792,0.843,no,GO:0009888,0.541
RSCID.459964.99918,GSE52327,Expression data of ALDH+ breast cancer cells,16,phenotype,ALDH+,ALDH-,66,NCI NIH HHS,0.827,no,no,no,0.767,0.822,0.652,no,GO:0050776,0.62
RSCID.453467.100080,GSE52478,The DNA Double-Strand Break Response Is Abnormal in Myeloblasts From Patients With Therapy-Related Acute Myeloid Leukemia,17,disease,trisomy 8; acute myeloid leukemia,acute myeloid leukemia,1,NHLBI NIH HHS,0.786,no,no,no,0.378,0.665,0.983,no,GO:0042571,0.5
RSCID.459329.39742,GSE5264,Human bronchial epithelial cell differentiation time course,22,individual,donor 2,donor 3,18,NA,0.95,no,no,no,NA,NA,0.643,no,GO:1901566,0.576
RSCID.455740.3646,GSE5281,steph-affy-human-433773,25,organism part,Hippocampus,Middle temporal gyrus,133,NA,0.82,no,no,no,NA,NA,0.718,no,GO:0051240,0.542
RSCID.455935.101003,GSE53012,"Expression data from three human cancer cell lines (PC-3, SK-OV-3, WM793B) exposed to  experimental cycling and chronic hypoxa in vitro",18,disease,ovarian cancer,Melanoma,1896,NA,0.8,yes,no,no,NA,NA,0.827,no,GO:0051270,0.519
RSCID.465190.121969,GSE53046,"C10ORF10/DEPP, a transcriptional target of FOXO3 regulates ROS-sensitivity by destabilizing peroxisomes in human neuroblastoma",6,cell line,SH-EP,C7H2,3080,NA,0.701,no,no,no,NA,NA,0.678,no,GO:0030054,0.516
RSCID.466978.124566,GSE53091,Inference and validation of predictive gene networks from biomedical literature and gene expression data,125,cell line,SW480 cell,SW620 cell,524,NA,0.827,yes,no,no,NA,NA,0.856,no,GO:0045595,0.539
RSCID.463614.121279,GSE53157,Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas,11,disease staging,follicular variants; Papillary thyroid carcinoma,reference subject role,85,NA,0.891,no,no,no,NA,NA,0.556,no,GO:0031012,0.563
RSCID.466990.124580,GSE53552,Gene expression profiling in psoriatic lesional and non-lesional skin [brodalumab treatment],99,disease,skin lesions,reference subject role,125,NA,0.896,yes,no,no,NA,NA,0.999,no,GO:0006955,0.578
RSCID.467012.124705,GSE53757,Gene array analysis of clear cell renal cell carcinoma tissue versus matched normal kidney tissue,144,disease,renal clear cell carcinoma,reference subject role,764,NCI NIH HHS,0.826,no,no,no,0.767,0.778,0.685,no,GO:0006082,0.54
RSCID.467026.124747,GSE53820,Gene expression data from serial samples of follicular lymphoma (FLSB - follicular lymphoma serial biopsies),77,disease staging,100% transformation; diffuse large B-cell lymphoma,reference subject role,83,NA,0.887,no,no,no,NA,NA,0.602,no,GO:0001775,0.578
RSCID.463673.118147,GSE53890,REST and Stress Resistance in Aging and Alzheimerâ€™s Disease,41,sex,female,male,4,NA,1,no,yes,no,NA,NA,1,no,GO:0010501,0.665
RSCID.445480.76142,GSE5460,Predicting Features of Breast Cancer with Gene Expression Patterns,75,genotype,ER+/HER2-,ER+/HER2+,12,NCI NIH HHS,0.724,no,no,no,0.721,0.765,0.53,no,GO:0046982,0.577
RSCID.463675.118593,GSE54992,Expression data from peripheral blood,15,disease,6 months post treatment; Tuberculosis,reference subject role,189,NA,0.828,no,no,no,NA,NA,0.712,no,GO:0030334,0.56
RSCID.457932.116561,GSE55609,Human meningioma culture,24,sex,male,female,6,NA,1,no,yes,no,NA,NA,1,no,GO:0060765,0.599
RSCID.463639.118431,GSE55945,Gene Expression Profiling of Prostate Benign and Malignant Tissue,16,disease staging,prostate cancer; malignant,reference subject role; benign,28,NCI NIH HHS,0.72,no,no,no,0.735,0.704,0.546,no,GO:0015672,0.55
RSCID.463653.118767,GSE56465,Comparison of haploid and diploid clones of KBM7 cancer cell line,24,genotype,diploid,wild type genotype,3285,NA,0.749,yes,no,no,NA,NA,0.751,no,GO:0006955,0.524
RSCID.444505.15775,GSE5682,Gene expression analysis of  gamma-secretase inhibitor-sensitive and -resistant T-ALL cell lines,20,genotype,GSI-sensitive,GSI-resistant,145,NCI NIH HHS,0.779,no,no,no,0.873,0.83,0.921,no,GO:0044092,0.527
RSCID.448676.76644,GSE5716,Gene expression analysis of T-ALL cell lines treated with gamma-secretase inhibitor,20,phenotype,Gamma secretase inhibitor; resistant to,Gamma secretase inhibitor; sensitive toward,158,NCI NIH HHS,0.772,no,no,no,0.855,0.819,0.885,no,GO:0045859,0.528
RSCID.463731.117365,GSE57255,Effect of EtOH on transcriptome signatures in human dental pulp stem cells,24,timepoint,48h,24h,127,NA,0.558,no,no,no,NA,NA,0.504,no,GO:0097367,0.536
RSCID.460019.100789,GSE5787,Survey of Intra- and Inter-Tumour Heterogeneity of Gene Expression in Cervical Cancer,8,individual,patient 6,patient 4,951,NA,0.865,yes,no,no,NA,NA,0.691,no,GO:0006955,0.549
RSCID.457143.73657,GSE5816,A Genome-wide Screen for Hypermethylated Genes in Lung Cancer,36,disease,immortalized bronchial epithelial cells,non-small cell lung carcinoma,1166,NCI NIH HHS,0.802,no,no,no,0.79,0.787,0.83,no,GO:0009888,0.528
RSCID.463612.121274,GSE58208,"Gene expression profiling of PBMC from normal individuals, chronic hepatitis B carriers and hepatocellular carcinoma patients",17,disease staging,hepatitis B,reference subject role,1,NA,0.977,no,no,no,NA,NA,0.999,no,GO:0005242,0.999
RSCID.450187.39808,GSE5823,Effects of RNA interference-mediated c-MYC depletion on gene expression profiles in human cancer cell lines,18,disease,breast cancer,cervical cancer,861,NA,0.557,no,no,no,NA,NA,0.507,no,GO:0043168,0.511
RSCID.449209.40167,GSE5900,"Gene Expression of Bone Marrow Plasma Cells from Healthy Donors (N=22), MGUS (N=44), and Smoldering Myeloma (N=12)",66,disease,monoclonal gammopathy of uncertain significance,reference subject role,18,NCI NIH HHS,0.587,no,no,no,0.635,0.601,0.559,no,GO:0007169,0.598
RSCID.459296.39107,GSE6088,Imprints of atherosclerosis are present in circulating T cells of patients with Familial Hypercholesterolemia,20,disease,heterozygous; familial hypercholesterolemia,reference subject role,60,NA,0.921,no,no,yes,NA,NA,0.575,no,GO:0006955,0.625
RSCID.449252.40080,GSE6283,Specific transcriptional changes in human fetus with autosomal trisomies,21,cell type,chorion villus cells,amniocytes,1118,NA,0.8,no,no,no,NA,NA,0.825,no,GO:0051240,0.528
RSCID.465239.122018,GSE67338,Expression data of human neuroblastoma IMR32 cells treated with the DHODH inhibitor Teriflunomide [118 ÂµM],6,treatment,teriflunomide,reference substance role,261,NA,0.735,no,no,no,NA,NA,NA,no,GO:0042981,0.532
RSCID.455853.16106,GSE6764,Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma,23,disease,cirrhotic liver,reference subject role,85,NIDDK NIH HHS,0.914,no,no,no,0.624,0.896,0.596,no,GO:0034097,0.634
RSCID.449134.74515,GSE6885,Transformed Human Breast Epithelial Cell Types vs. Normal Cell-of-Origin,11,cell type,transformed tumorigenic HMLER,untransformed hTERT immortalized BPE,764,NCI NIH HHS,0.812,no,no,no,0.814,0.811,0.847,no,GO:0030054,0.53
RSCID.449149.77544,GSE6920,Gene expression profiling of LMO2 associated T cell lymphoblastic leukemia induced by insertional mutagenesis,4,cell type,T-cell acute lymphoblastic leukemias; primary cell culture,bone marrow; NOD mice; SCID mice; T-cell acute lymphoblastic leukemias,486,NA,0.706,no,no,no,NA,NA,0.58,no,GO:0007049,0.537
RSCID.459307.76595,GSE7014,"Expression data from DM1, DM2 and Normal Adult Skeletal Muscle Biopsies",26,disease,myotonic dystrophy type 2,reference subject role,140,NA,0.844,no,no,no,NA,NA,0.634,no,GO:0006952,0.535
RSCID.457506.72893,GSE7214,Comparison of gene expression data between wild-type and DM1-affected cells,18,cell type,Precursor Cell; Neuron,embryonic stem cell; undifferentiated,511,NA,0.82,no,no,no,NA,NA,0.858,no,GO:0045595,0.562
RSCID.442240.16190,GSE7305,Human endometriosis vs normal endometrium study - transcriptional profiling,20,disease,Endometriosis,reference subject role,366,NA,0.904,no,no,no,NA,NA,0.917,no,GO:0031012,0.54
RSCID.456264.108631,GSE7392,Molecular Evidence of Injury and Inflammation in Normal and Fibrotic Renal Allografts One Year Post-Transplant,30,timepoint,12 months,0 months,41,NA,0.956,no,no,no,NA,NA,0.581,no,GO:0071495,0.633
RSCID.456283.16420,GSE7400,Microarray Analysis of the G-CSF-mobilized Peripheral Blood Stem Cell Allograft,10,treatment,granulocyte-colony stimulating factor (G-CSF); post,prior; granulocyte-colony stimulating factor (G-CSF); reference subject role,273,NA,0.882,yes,no,no,NA,NA,0.883,no,GO:0006955,0.578
RSCID.465006.121944,GSE74195,Differential expression and prognostic significant of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis,32,disease staging,childhood medulloblastoma,reference subject role; cerebellum,302,NA,0.818,no,no,no,NA,NA,0.833,no,GO:0022008,0.551
RSCID.464839.121779,GSE74304,"Gene expression data of GBM146 and GBM157 at day0, 7, 30 after serum exposure",10,cell line,GBM146,GBM157,22,NINDS NIH HHS,0.808,no,no,no,0.666,0.788,NA,no,GO:0010243,0.56
RSCID.456026.111071,GSE7440,Early Response and Outcome in High-Risk Childhood Acute Lymphoblastic Leukemia: A Childrenâ€™s Oncology Group Study,71,clinical history,no followup,relapse,1,NCI NIH HHS,0.774,no,no,no,0.869,0.755,0.467,no,GO:0030018,0.998
RSCID.444370.17008,GSE7476,Analysis of clinical bladder cancer classification according to microarray expression profiles,6,disease,TaLG; cancer,reference subject role,677,NA,0.896,yes,no,no,NA,NA,0.913,no,GO:0031012,0.545
RSCID.455951.15805,GSE7509,Gene expression changes in anti-FcgRIIb treated DCs and monocytes,19,cell type,dendritic cell; immature,monocyte,322,NIAID NIH HHS,0.853,no,no,no,0.756,0.85,0.751,no,GO:0006955,0.571
RSCID.459091.20256,GSE7513,Gene expression data from CD44+/CD24- cells sorted by flow cytometry,29,cell type,CD24-; CD44+,reference subject role,211,NCI NIH HHS,0.898,no,no,no,0.871,0.886,0.881,no,GO:0006955,0.567
RSCID.456767.20219,GSE7515,Gene expression data from cancer mammospheres and bulk tumors,26,cell type,Tissue; mammary cancer; mammary gland tumor,mammosphere; primary cell culture,440,NCI NIH HHS,0.903,no,no,no,0.882,0.885,0.902,no,GO:0006928,0.541
RSCID.459297.64951,GSE7538,Treatment of primary acute myelogenous leukemia (AML) specimens with parthenolide (PTL),24,treatment,parthenolide,reference subject role,39,NCI NIH HHS,0.823,no,no,no,0.757,0.798,NA,no,GO:0006952,0.575
RSCID.449213.39243,GSE7553,Gene Expression Patterns Involved in the Malignant Transformation and Progression of Metastatic Melanoma,44,disease,Melanoma; metastatic,skin; reference subject role,1425,NCRR NIH HHS,0.784,yes,no,no,0.608,0.788,0.803,no,GO:0009888,0.539
RSCID.456617.17686,GSE7562,Identification of the JNK Signaling Pathway as a Functional Target of the Tumor Suppressor PTEN,12,genotype,knockdown; PTEN [human] phosphatase and tensin homolog,wild type genotype,1,NIGMS NIH HHS,0.635,no,no,no,0.389,0.817,0.467,no,GO:0043491,0.999
RSCID.441047.39436,GSE7568,Effects of TGF-beta on mature macrophages,11,treatment,24 hrs; TGF-beta (transforming growth factor-beta); dexamethasone,reference subject role,3842,NA,0.621,yes,no,no,NA,NA,0.658,no,GO:0006928,0.516
RSCID.456267.34725,GSE7586,Genome wide analysis of placental malaria,12,disease,chronic PM with inflammation,Healthy; reference subject role,50,NHLBI NIH HHS,0.93,no,no,no,0.78,0.919,0.926,no,GO:0006955,0.711
RSCID.460575.17098,GSE7621,Expression data of substantia nigra from postmortem human brain of Parkinson's disease patients (PD),25,sex,male,female,24,NA,0.96,no,no,no,NA,NA,0.718,no,GO:0034097,0.614
RSCID.456033.108639,GSE7637,Expression data from human mesenchymal stem cells (#4F1560),12,timepoint,passage 7,passage 5,173,NA,0.799,no,no,no,NA,NA,0.67,no,GO:0022402,0.58
RSCID.456271.111596,GSE7696,Glioblastoma from a homogenous cohort of patients treated within clinical trial,47,disease,radiotherapy; temozolomide; Glioblastoma,reference subject role,573,NA,0.825,no,no,no,NA,NA,0.911,no,GO:0097458,0.551
RSCID.448362.34883,GSE7700,Genes regulated by YAP in normal breast cell line and breast cancer cell lines,10,genetic modification,"knock-down; YAP1 [human] Yes-associated protein 1, 65kDa",wild type genotype,10,NA,0.974,no,no,no,NA,NA,0.556,no,GO:0031012,0.69
RSCID.455810.15518,GSE7708,Suppression of androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide,14,treatment,stimulated with DHT,unstimulated with DHT,84,NIGMS NIH HHS,0.847,no,no,no,0.751,0.844,0.726,no,GO:0030334,0.548
RSCID.448313.34069,GSE7753,Gene Expression Profiling in Peripheral Blood in Untreated New Onset Systemic Juvenile Idiopathic Arthritis,47,disease,juvenile rheumatoid arthritis,reference subject role,40,NA,0.884,no,no,no,NA,NA,0.593,no,GO:0006952,0.598
RSCID.441048.75739,GSE7788,Nodular lymphocyte predominant Hodgkin's lymphoma vs T cell/histiocyte rich B cell lymphoma,11,disease,"nodular lymphocyte predominant; Hodgkin's disease, unspecified type; lymph node",reference subject role; lymph node,51,NA,0.842,no,no,no,NA,NA,0.539,no,GO:0015630,0.578
RSCID.448229.74276,GSE7835,Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface,6,treatment,Untreated LNCaP cells not stimulated with DHT,Untreated LNCaP cells stimulated with DHT,224,NIGMS NIH HHS,0.708,yes,no,no,0.595,0.694,NA,no,GO:0007049,0.533
RSCID.456272.101896,GSE7869,Expression data from renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients,8,organism part,Minimally cystic tissue,renal cortex,115,NA,0.816,no,no,no,NA,NA,NA,no,GO:0006629,0.563
RSCID.456040.102680,GSE7888,Expression data from human mesenchymal stem cells (six batches),17,treatment,middle stage,senescent,53,NA,0.894,no,no,no,NA,NA,0.787,no,GO:0071495,0.569
RSCID.457137.64956,GSE7904,Expression data from human breast tissue,28,disease,non-basal like cancer,reference subject role,273,NA,0.926,no,no,no,NA,NA,0.97,no,GO:0009888,0.57
RSCID.448311.34850,GSE7967,Activation of inflammation and nfkb signaling in infants born to arsenic exposed mothers,64,environmental history,Arsenic Poisoning,reference subject role,14,NA,0.992,yes,no,no,NA,NA,0.73,no,GO:0030335,0.67
RSCID.456184.15867,GSE8121,Pediatric septic shock,45,disease,septic shock; Day 3,reference subject role,51,NIGMS NIH HHS,0.941,no,no,no,0.992,0.961,0.998,yes,GO:0006955,0.631
RSCID.456274.108761,GSE8167,Distinct gene-expression-defined classes of gastrointestinal stromal tumor (GIST).,32,organism part,small intestine,stomach,215,NA,0.843,no,no,no,NA,NA,0.748,no,GO:0051240,0.551
RSCID.456051.15972,GSE8507,Neutrophil and PBMC gene expression data from Job's Syndrome,141,disease,Job's Syndrome,reference subject role,36,NCI NIH HHS,0.772,no,no,no,0.691,0.792,NA,no,GO:0060589,0.548
RSCID.456236.15496,GSE8514,Expression data from normal adrenal gland and aldosterone-producing adenoma,15,disease,aldosterone; Adenoma,reference subject role,64,NIDDK NIH HHS,0.824,no,no,no,0.578,0.781,0.593,no,GO:0006952,0.561
RSCID.456179.108766,GSE8527,Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent pneumococci,11,treatment,Streptococcus pneumoniae G54,reference subject role,1,NA,0.987,no,no,no,NA,NA,NA,no,GO:0034122,0.999
RSCID.455995.15610,GSE8596,Expression profiles of pediatric solid tumor cell lines,8,cell line,Ewing family tumor,UET-13,346,NA,0.839,no,no,no,NA,NA,0.868,no,GO:0051270,0.545
RSCID.456071.15797,GSE8597,Gene expression analysis of hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide,8,treatment,estradiol; dimethyl sulfoxide,ethanol; cycloheximide,327,NA,0.783,no,no,no,NA,NA,0.666,no,GO:0022402,0.588
RSCID.456064.15606,GSE8665,The effects of chimeric EWS/ETS protein in human mesenchymal progenitor cells (MPCs).,14,cell line,ERG,FLI1,66,NA,0.889,yes,no,no,NA,NA,0.786,no,GO:0097458,0.565
RSCID.440722.39777,GSE8668,Effects of exercise on gene expression in human neutrophils,24,treatment,after exercise,reference subject role,2,NCRR NIH HHS,0.941,no,no,no,0.975,0.966,0.75,no,GO:0032731,0.749
RSCID.456069.16738,GSE8671,Transcriptome profile of human colorectal adenomas.,64,disease,Adenoma,normal,304,NA,0.896,yes,no,no,NA,NA,0.886,no,GO:0040012,0.548
RSCID.458474.75566,GSE8685,"Activation of Sez-4 cell line with IL-2, IL-15 or IL-21.",6,treatment,IL15 [human] interleukin 15,reference substance role,192,NCI NIH HHS,0.647,no,no,no,0.621,0.646,NA,no,GO:0051046,0.535
RSCID.458473.116704,GSE8687,Inhibition of activation of Sez-4 cell line with IL-2 by Jak kinase inhibitors.,12,treatment,Interleukin-2,reference substance role,248,NCI NIH HHS,0.684,no,no,no,0.649,0.675,0.531,no,GO:1902533,0.542
RSCID.456286.15435,GSE8717,Expression data from Human MPNST cancer cells infected with G207 and oncolytic HSV,22,treatment,infected with G207,reference substance role,243,NA,0.687,no,no,no,NA,NA,0.525,no,GO:0043067,0.543
RSCID.458923.34727,GSE8866,The undifferentiated phenotype in neuroblastoma depends on Cyclin D1 and CDK4 activity,7,genetic modification,vehicle,reference subject role,21,NA,0.841,no,no,no,NA,NA,0.526,no,GO:0048699,0.597
RSCID.445042.19581,GSE8896,Flagellin-mediated effects of Salmonella enteritidis on gene expression in intestinal epithelial cells,6,treatment,EAV9; Salmonella enteritidis,S1400; Salmonella enteritidis; wild type genotype,48,NA,0.894,yes,no,no,NA,NA,0.819,no,GO:0042981,0.668
RSCID.456187.102469,GSE8977,Bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis,22,disease,invasive ductal carcinoma,reference subject role,102,NCI NIH HHS,0.928,no,no,no,0.883,0.9,0.607,no,GO:0002684,0.56
RSCID.461591.75537,GSE9031,Myeloma versus Lymphoma cell lines,11,cell type,myeloma,GCB-DLBCL,515,Intramural NIH HHS,0.752,no,no,no,0.514,0.719,0.798,no,GO:0006955,0.531
RSCID.444388.15584,GSE9101,Expression data in native lipoprotein-stimulated human THP-1 macrophages,12,treatment,very-low-density lipoprotein; Lipoprotein; Low density lipoprotein; High densitiy lipoprotein,reference subject role,39,NA,0.941,no,no,no,NA,NA,0.549,no,GO:0002684,0.678
RSCID.448381.34925,GSE9169,Gene expression during neuronal differentiation in two subtypes of SH-SY5Y,66,cell line,ECACC; SH-SY5Y,SH-SY5Y; ATCC,476,NA,0.758,no,no,no,NA,NA,0.677,no,GO:0022008,0.535
RSCID.459534.70497,GSE9348,Expression data from healthy controls and early stage CRC patient's tumor,82,disease,healthy control,early stage; Colorectal Cancer,437,NA,0.858,yes,no,no,NA,NA,0.884,no,GO:0042592,0.532
RSCID.458687.19413,GSE9451,Identification of Signature Molecule-Marked Native Mesenchymal Stem Cells,6,cell type,osteoblast; mesenchymal cell,mesenchymal cell; chondrocyte,471,NA,0.849,yes,no,no,NA,NA,0.86,no,GO:0045595,0.55
RSCID.458686.19417,GSE9576,Gene expression profiling of classical midgut carcinoid primary tumors and liver metastasis,6,disease,"Liver Metastases; Carcinoma, Neuroendocrine",scraped; normal; ileal mucosa,1346,NA,0.767,no,no,no,NA,NA,0.764,no,GO:0022892,0.521
RSCID.456208.110897,GSE9599,Coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition in pancreatic cancer,36,phenotype,EGFR inhibitor sensitive,EGFR inhibitor resistant,120,NCI NIH HHS,0.903,yes,no,no,0.875,0.882,0.596,no,GO:0009888,0.546
RSCID.456300.3619,GSE9770,Mild cognitive impairment - neuronal expression (6 regions),12,organism part,CA1 field of hippocampus,Entorhinal cortex,126,NA,0.826,no,no,no,NA,NA,0.783,no,GO:0045595,0.553
RSCID.464895.121831,GSE9807,Expression data from RNAi SNCA treated human neuroblastoma cell line,6,genotype,"Knockdown; SNCA [human] synuclein, alpha (non A4 component of amyloid precursor)",wild type genotype,1,NA,0.772,no,no,no,NA,NA,0.467,no,GO:0005070,0.998
RSCID.456214.110861,GSE9844,Transcriptomic Dissection of Tongue Squamous Cell Carcinoma,38,disease,Oral Tongue Squamous Cell Carcinoma,reference subject role,128,NA,0.875,yes,no,no,NA,NA,0.683,no,GO:0009888,0.562
RSCID.457030.39485,GSE9988,Innate immune repsonses to TREM-1 activation,21,treatment,Lipopolysaccharide,reference substance role,165,NA,0.857,no,no,no,NA,NA,0.857,no,GO:0006952,0.593
